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Abstract 
The purpose of this review is to analyze evidence on prevalence of opioid, alcohol and marijuana 
use during pregnancy and answer the PICOT question:  In pregnant women addicted to or using 
marijuana, opioids, and alcohol, how do non-pharmacological interventions, compared to 
standard care of pharmacological interventions alone, affect health outcomes in mothers and 
neonates from birth to hospital discharge?  Diagnosis of substance use disorder among pregnant 
women is increasing and with it comes increased risk of complications to mother and neonate 
including neonatal abstinence syndrome (NAS), fetal alcohol syndrome (FAS) and other 
negative neonatal and maternal outcomes.  Evidence was reviewed from the online databases, 
PubMed and CINAHL.  Twenty studies from 2013-2018 were reviewed.  Interventions included 
specialized comprehensive care, individual care, motivational interviewing (MI), and brief 
intervention. There was limited research about the topic, indicating a need for more research to 
find the most effective non-pharmacological interventions for these populations.  
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There is a rising substance abuse epidemic in the United States (Krans, Bobby, England, 
Gedeko, Change, Maguire, Genday, & English, 2018) that affects vulnerable populations who 
may be especially susceptible to health-related complications.  This epidemic includes pregnant 
mothers abusing opioids, alcohol, or marijuana and their neonates affected by this abuse.  Recent 
studies have shown that between 1998 and 2011, opioid use among pregnant women has 
increased 127% (Krans et al., 2018).  A substantial number of women, against recommendations, 
continue to drink alcohol during pregnancy (Savory, Couves, & Burns, 2014).  The rate of 
marijuana use has also significantly increased in the past 15 years (Coleman-Cowger, Oga, 
Peters, & Mark, 2018).  Due to the increase of substance abuse in pregnancy, both the pregnant 
mothers and neonates are affected negatively (Krans et al., 2018).    
Opioid related deaths from overdose have quadrupled since 1999 in the U.S., resulting in 
about 78 deaths per day (Metz, Brown, Martins, & Palamar, 2017).  With the increase in opioid 
use in pregnant mothers, more children are being born with Neonatal Abstinence Syndrome 
(NAS) (Metz, Brown, Martins, & Palamar, 2017).  Neonatal Abstinence Syndrome is a 
withdrawal syndrome exhibited by opioid-dependent neonates.  This syndrome is characterized 
by a wide variety of signs and symptoms including feeding difficulties, tremors/seizures, high 
pitched cries, poor body temperature control, and other symptoms similar to that of opioid 
withdrawal (Patrick, Dudley, Martin, Harrell, Warren, Hatmann, & Cooper, 2018).  Neonatal 
Abstinence Syndrome is extremely dangerous and can lead to neonatal deaths.  Hospital costs for 
opioid addicted mothers and neonates have risen from $32 million in 2009 to $1.5 billion in 2012 
(Metz, Brown, Martins, & Palamar, 2017).  In reproductive-aged women, around one-third have 
a prescription for an opioid analgesic (Bakhireva, Shrestha, Garrison, Leeman, Rayburn, & 
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Stephen, 2018).  It is evident that this problem is a significant crisis in the U.S. and calls for 
further attention, especially from nurses who manage the care of these women and neonates.   
Alcohol consumption during pregnancy is important to study because it results in harmful 
risks in both mothers and neonates.  Consumption of alcohol during pregnancy increases risk for 
certain fetal alcohol spectrum disorders (FASD), such as fetal alcohol syndrome (FAS), partial 
fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder (May, Chambers, 
Kalberg, Zellner, Feldman, Buckley, Kopald, Hasken, Xu, Honerkamp-Smith, Taras, Manning, 
Robinson, Adam, Abdul-Rahman, Vaux, Jewett, Elliott, Kable, Akshoomoff, Falk, Arroyo, 
Hereld, Riley, Charness, Coles, Warren, Jones, & Hoyme, 2018).  Approximately 30.3% of 
United States pregnancies are affected by prenatal alcohol exposure (PAE) (May et al., 2018).  
FASDs are associated with lifelong neurodevelopmental and behavioral disabilities in children, 
yet these disorders have received little attention in the research on prevention or treatment 
strategies (May et al., 2018). 
Marijuana is one of the most commonly used illicit substances during pregnancy (Mark, 
Desai, & Terplan, 2015).  Within the last decade, marijuana abuse in pregnancy has increased 
35% (Mark, Desai, & Terplan, 2015).  Use of marijuana during pregnancy increases risk in 
pregnancy and neonatal development.  These risks include preterm labor, low birth weight, 
stillbirth, and neonatal intensive care unit admissions (Mark, Desai, & Terplan, 2015), as well as 
differences in neonatal behaviors (Coleman-Cowger, Oga, Peters, & Mark, 2018).  These risks 
have been shown to decrease or become nonexistent with effective preventative interventions 
and treatments (Mark, Desai, & Terplan, 2015).  Because the harms of marijuana use for a 
pregnant woman and her fetus have not been fully explored and the possibility of unknown side 
effects, The American College of Obstetricians and Gynecologists (ACOG) recommends that 
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pregnant women not use marijuana (2019).  As marijuana use is legalized across the country 
(Mark, Desai, & Terplan, 2015), use in pregnant women may also increase, therefore research 
into adverse effects should be investigated.  
Hospitals around the United States are seeing an increase in neonatal repercussions 
related to maternal substance use and abuse (Patrick et al., 2018).  Pharmacological treatments 
are often supplied to wean mothers and neonates off addictive substances but these alone are not 
enough to treat these complicated addictions.  While pharmacological interventions provide 
beneficial outcomes in treatment by minimizing withdrawal symptoms and cravings, they cannot 
help prevent relapse or provide patient education on maintaining a healthy lifestyle for both 
mothers and children (Andrews, Motz, Pepler, Jeong, & Khoury, 2018).  Addiction is a 
multifaceted disease which requires a multifaceted approach to treatment.  Mothers who used 
substances also need integrated, multi-faceted interventions to support the cessation of substance 
use during and following pregnancy (Andrews et al., 2018).  To provide the most comprehensive 
care, evidence based non-pharmacological interventions need to be examined, critically 
appraised, and applied, in addition to the standard practice of pharmacological treatment 
(Andrews et al., 2018). 
In this systematic review, evidence about the effects of supplemental non-
pharmacological interventions, compared with pharmacological interventions alone, in pregnant 
mothers and neonates will be identified, reviewed, and critically appraised with practice 
recommendations advanced.  The purpose of this review is to investigate evidence regarding the 
prevalence of opioid, alcohol, and marijuana use during pregnancy as well as 
nonpharmacological interventions to benefit neonate and mother.  The following question will be 
answered: In pregnant women addicted to or using marijuana, opioids, and alcohol, how do 
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supplemental non-pharmacological interventions, compared to standard care of pharmacological 
interventions alone, affect health outcomes in mothers and neonates between birth to hospital 
discharge?  This is relevant to the nursing community due to the increase in diagnoses of 
substance abuse disorder (Patrick et al., 2018) in women and the increase in negative outcomes 
for neonates due to exposure to both licit and illicit substances (Andrews et al., 2018).  Recent 
studies from the Center of Disease Control and Prevention (CDC) (“Substance Use During 
Pregnancy,” 2019) have shown that from 1999 to 2014 opioid use in pregnancy has quadrupled. 
Along with this, it is proved that alcohol use in pregnancy has shown long term effects on 
neonates, including a variety of Fetal Alcohol Disorders (FADs) (“Fetal Alcohol Spectrum 
Disorders…,” 2018).  There is still little research done on marijuana use during pregnancy; 
common known effects are low birth weight and problems concentrating as the neonate grows 
older (“What You Need to…,” 2018).  These facts further support and advocate for the need for 
nurses to gain knowledge of this subject and more research to be done.   
Methods 
The articles used for this systematic review were carefully selected using a strict 
inclusion and exclusion criteria.  Only articles published from 2012-2018 were considered to 
review the most current research.  Articles were examined to ensure they were peer-reviewed, 
and findings were evidence-based.  Journals and articles were selected based on credibility and 
relevance to the PICOT question.  Preference was given to nursing journals. 
The population focus of this systematic review is pregnant women with substance abuse 
and affected neonates.  While selecting articles, only articles with the primary population being 
substance abusing pregnant women and affected neonates were used.  Studies were not limited to 
research conducted in the United States, as research conducted in other countries has generated 
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relevant evidence for practice in the U.S.  Articles focusing on pharmacological methods of 
treating addicted women were not considered.  Since this review is centered on 
nonpharmacological approaches, research about various therapies and alternative methods were 
selected.   
When searching for articles, a variety of databases were used including PubMed and 
CINAHL.  These databases heavily focus on nursing research.  An openness to inconsistencies 
and contradictions in findings, extensive research into various topical possibilities and use of 
diverse keywords in each database search engine were implemented in selection of articles to 
ensure that the review is comprehensive and as unbiased as possible.  Keywords included: 
“pregnant”, “women”, “addiction”, “treatment”, “therapy”, “substance abuse”, and other specific 
substances. When searching for research articles based solely on marijuana intervention, studies 
were very difficult to find and should be noted as implication for future research.  
In the critical analysis of each article, it was necessary for the content to be clear and 
concise for consideration in this systematic review.  Studies must have used reliable, adequate 
samples or explanation of sample inclusion and exclusion criteria.  The articles must meet the 
strict criteria of this review as mentioned above, and should discuss limitations, especially those 
affecting generalizability and show minimal bias. 
 The content of each article was critically analyzed, leading to the decision to include 
them in this systematic review based on inclusion parameters stated above.  However, it was 
difficult to find many studies answering the PICOT question.  Therefore, almost all relevant 
studies about interventions for pregnant women addicted to substances were utilized throughout 
this systematic review.  As more research is done on this prevalent issue, increased 
understanding will be generated about the effectiveness of interventions.  
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Review of Literature 
Opioid Abuse 
Prevalence.  Several studies were found regarding opioid use during pregnancy.  Two 
focused on cohorts to find prevalence of opioid use in pregnant women.  In general, researchers 
agreed that opioid use during pregnancy is a growing problem that needs to be 
addressed.  Angellota, Weiss, and Friedman (2016) found that in 2012, roughly 1.2% of pregnant 
women in the United States are addicted to opioids.  These researchers found a positive 
correlation between unintended pregnancies and opioid use.  Additionally, Metz, Brown, 
Martins, & Palamar (2017) found that since 1999, opioid overdose resulting in death has 
quadrupled.  Polysubstance abuse is another problem many pregnant women are dealing with.  
Metz, Brown, Martins, & Palamar (2017) found that of pregnant women with substance abuse 
disorder (n=818), 36.8% (n=281) used opioids exclusively, 28.2% (n=241) were polysubstance 
users, and 35.0% (n=296) used non-opioid illegal substances.  Limitations in this study include 
unaccounted for trends, exclusion of institutionalized women, and the inability to infer causality.  
Nørgaard, Nielsson, & Heide-Jørgensen (2015) found that out of 950,172 Danish women, 557 
(5.9%) were tested positive for opioid use.  Exclusive use of the opioid buprenorphine occurred 
in 167 pregnancies, and exclusive use of the opioid methadone occurred in 197 
pregnancies.  Twenty-eight women reported using heroin only, and 165 used a combination 
(Nørgaard, Nielsson, & Heide-Jørgensen, 2015).  These two studies clearly show that 
polysubstance abuse in pregnancy is a significant problem.  The number of people who 
developed Opioid use disorder (OUD) has gotten so high that the U.S. Department of Health and 
Human Services (HHS) has declared a public health emergency in 2017 (“What is the U.S. 
Opioid Epidemic?” 2019). 
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Prevalence and outcomes in newborns.  The increasing prevalence of pregnant women 
with OUD has led to an increase in neonates born with Neonatal Abstinence Syndrome (NAS; 
Metz, Brown, Martins, & Palamar, 2017).  Because the effects of opioids travel to the neonates 
through the placenta, neonates are at risk for NAS and other adverse reactions (Nørgaard, 
Nielsson, & Heide-Jørgensen, 2015; Patrick et al., 2015).  For example, in a sample of 950,172 
pregnant women, the median birth weights for neonates affected by opioid addiction during 
pregnancy (n=557) were less than the median birth weight of neonates that were not affected 
(n=949,615) (Nørgaard, Nielsson, & Heide-Jørgensen, 2015; Patrick et al., 2015).  Nørgaard, 
Nielsson, & Heide-Jørgensen (2015) also found genital malformations in 46 of the neonates 
affected by addiction to opioids during pregnancy.  Preterm delivery was prevalent in opioid 
exposed neonates (Nørgaard, Nielsson, & Heide-Jørgensen, 2015), as well as respiratory disease, 
jaundice, and problems with feeding (Patrick et al., 2015).  Patrick et al. (2015) findings are 
limited due to potential errors in medical records, not knowing if mothers were taking their 
prescription opioids as prescribed, and the inability to account for any illegal substances that may 
have been used during the trial.  Nørgaard, Nielsson, & Heide-Jørgensen, (2015) and Patrick et 
al. (2015) both found that opioid exposed neonates are more susceptible to complications than 
non-opioid exposed neonates, and that NAS negatively impacts neonatal development.  
According to the CDC, in the latest data available reported in 2014, a neonate is born with NAS 
every 15 minutes (“Pregnancy: Neonatal Abstinence Syndrome,” 2019).  This is nearly 100 
babies a day; about 32,000 babies a year (“Pregnancy: Neonatal Abstinence Syndrome,” 2019). 
Nursing interventions.  Researchers have examined the effects of various interventions 
to decrease the use of opioids in pregnant women and decrease the negative impact on their 
neonates.  For example, four studies were found on interventions for mothers and neonates 
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affected by opioid use disorder; two studies were about specialized comprehensive care 
interventions (Andrews et al., 2018; Krans et al., 2018) and two were about individual 
interventions (Howard, Schiff, Penwill, Si, Rai, Wolfgang, Moses, & Wachman, 2017; Lander, 
Gurka, Marshalek, Riffon, & Sullivan, 2015).  In general, the interventions found to be most 
effective in mothers and their neonates involved specialized comprehensive care that included 
treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018; Lander et 
al., 2015), prevention of relapse (Andrews et al., 2018; Krans et al., 2018; Lander et al., 2015), 
patient education (Andrews et al., 2018; Howard et al., 2017), and maintaining healthy mother-
child relationships (Andrews et al., 2018; Krans et al., 2018; Howard et al., 2017).  Pregnant 
women who participated in specialized comprehensive interventions were more likely to attend 
postpartum visits (67.9% vs 52.6%; intervention group n=71, control group n=177; Krans et al., 
2018), have increased rates of breastfeeding during childbirth hospitalization  (14.7% vs. 37.0%; 
Krans et al., 2018), receive long-acting reversible contraceptive methods following deliveries of 
neonates (23.9% vs. 13.0%; Krans et al., 2018), maintain custody of their children (60.6%; 
n=160; Andrews et al., 2018), and end services with goals met if they attended services with 
regular frequency (18.8%; Andrews et al., 2018).  Howard et al. (2017) found that parental 
presence also known as rooming-in was documented at 68% (n=86) and the mean Neonatal 
Abstinence Syndrome (NAS) was significantly lower in neonates who were breastfed.  A 100% 
parental presence was significantly associated with a one point decrease in the mean NAS score 
(-0.52 to -0.15), a nine day decrease in the length of stay (-0.48 to -0.10), and eight fewer days of 
opioid therapy (-0.52 to -0.15; Howard et al., 2017).  Findings from these studies support the 
continuous need for new non-pharmacological interventions to be implemented into healthcare. 
Alcohol Abuse  
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Prevalence.  Researchers have examined the prevalence of alcohol abuse in pregnant 
women.  Two studies were found on the prevalence of alcohol consumption during 
pregnancy.  Researchers have examined cross-sectional data on prevalence (Savory, Couves, & 
Burns, 2014) as well as prospectively on prevalence in both alcohol use disorder in correlation 
with other substances (Bakhireva et al., 2018).  In general, researchers have found that 
prevalence of alcohol abuse in mothers ranged from 8.5% to 30.3% (Bakhireva et al., 2018).  In a 
cross-sectional survey of pregnant women (n=470), Savory, Couves, and Burns (2014) found 
that 74% reported no drinking in the past 3 months, 18% reported monthly drinking or less, and 
7.8% reported frequent drinking.  This survey sample comprised of pregnant women attending 
their first antenatal appointments during an estimated 10-11 weeks gestation (Savory, Couves, & 
Burns, 2014).  Alcohol consumption is prevalent early in pregnancy as well in the 
periconceptional period.  In a study of 660 pregnancies, Bakhireva et al. (2018) found that 15% 
of pregnant women (n=660) consumed on average at least three drinks per week, consistent with 
the national report of 8.5% to 30.3% prevalence for alcohol use during pregnancy (Bakhireva et 
al., 2018).  Findings from both studies support the need for more interventions and education 
provided for patients suffering from these conditions. 
Prevalence and outcomes in neonates.  Studies have been done to examine the 
prevalence of alcohol abuse in pregnancy and the outcomes in neonates; two studies were found 
relevant to this systematic review.  Researchers have studied prevalence by using an active-case 
ascertainment with a cross-sectional design (May et al., 2018) and in a case study regarding one 
school of students (Lubbe, Walbeek, & Vellios, 2017).  Lubbe, Walbeek, & Vellios (2017) found 
an increase prevalence of adverse outcomes in newborns, such as Fetal Alcohol Syndrome.  May 
et al. (2018) found no increase in prevalence.  There are some inconsistent findings reported by 
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the two groups of researchers. Lubbe, Walbeek, & Vellios (2017) reported prevalence of fetal 
alcohol disorder at 12.7% (127 per 1000 people) in a sample of 166. These findings are 
inconsistent with May et al., (2018)  who found estimated prevalence as a wide range of 9.7 to 
50.4 per 1000 children (n=6639), which is comparable to the national average and a decrease 
from the findings from Lubbe, Walbeek, & Vellios (2017).  Reasons to why this may be is that 
Lubbe, Walbeek, & Vellios (2017) focused mainly on fetal alcohol disorder while May et al. 
(2018) focused on the full spectrum of alcohol causing disorders.  A major limitation of the case 
study (Lubbe, Walbeek, & Vellios, 2017), compared to the cross-sectional study (May et al., 
2018), is that it would be difficult to compare findings to other studies since it only focused on 
Fetal Alcohol Disorder specifically.  It also had a small sample of 166 students in one area of 
South Africa, which could influence the results (Lubbe, Walbeek, & Vellios, 2017).  Even 
though there is a difference in prevalence in findings in these two studies, it is still essential for 
new interventions to be put in place to decrease the long term and harmful effects of alcohol use 
during pregnancy.   
Nursing interventions.  Researchers have examined a diverse set of interventions for 
pregnant women who use alcohol during pregnancy, such as motivational interviewing (MI; 
Osterman, Carle, Ammerman, & Gates, 2014; Rendall-Mkosi, Morojele, London, Moodley, 
Singh, & Girdler-Brown, 2012) and brief interventions of counseling.  All aimed to decrease the 
risk of alcohol consumption during pregnancy (Kaner, Bland, Cassidy, Coulton, Dale, Deuca, 
Gilvarry, Godfrey, Heather, Myles, Newbury-Birch, Oyefeso, Parrott, Perryman, Phillips, 
Shepherd, & Drummond, 2013).  In general, researchers have found that multiple sessions of MI, 
which is a holistic approach to counseling aimed at helping individuals make choices about 
behavior, had positive results in decreasing alcohol consumption during pregnancy (Osterman et 
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al., 2014; Rendall-Mkosi et al., 2012).  The effectiveness of MI increased when used longer than 
one-month duration whether during pregnancy or in anticipation of pregnancy (Rendall-Mkosi et 
al., 2012).  For example, in a sample of 165 women aged 18-44 years, researchers found that a 
five session MI intervention was effective for women at risk for giving birth to neonates with 
FAS.  Regular implementation of MI was also found effective as part of routine pregnancy care 
(n=165; Rendall-Mkosi et al., 2012).  In contrast, a single session MI intervention was not 
effective in decreasing alcohol consumption (N=122; Osterman et al., 2014).  Two 15-minute 
brief interventions of brief counseling, provided by a physician with follow-up phone calls 
(N=3562; Kaner et al., 2013), were found to be an ineffective intervention to decrease alcohol 
consumption.  In summary, MI, a theory-based intervention, when used to decrease maternal 
intake of alcohol before and during pregnancy, has been used effectively when women attend 
multiple sessions although the specific reason for success has yet to be investigated (Osterman et 
al., 2014). 
Marijuana Abuse 
Prevalence.  Researchers have found recent increases in marijuana use in women of 
childbearing age.  In general, that marijuana abuse among women of childbearing age increased 
by 35%, according to hospital admission records from 1998 to 2003 in the United States (Mark, 
Desai, & Terplan, 2015).  From 2005-2014, Coleman-Cowger, Oga, Peters, & Mark (2018) 
found that 1% of pregnant women in the United States admitted to marijuana use.  However, the 
actual number of users could be higher, because perhaps pregnant women under-report use 
because of social desirability and fear that parenting may be questioned.  Mark, Desai, & Terplan 
(2015) found that pregnant marijuana users were less likely to graduate from high school and 
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more likely to be unemployed than those who had a negative marijuana screen.  They were also 
more likely to report feelings of depression. 
 In a study of 396 pregnant women, Mark, Desai, & Terplan (2015) found that 116 of 
these women tested positive for marijuana during prenatal care, and only three produced a 
positive toxicology screen at the time of delivery.  There is a lack of research on the prevalence 
of marijuana use in pregnant women, however, those studying this problem have found slight 
increases in marijuana use among pregnant women. 
Prevalence and outcomes in neonates.  Few researchers have examined the effects and 
outcomes in newborns who are exposed to marijuana abuse prenatally.  Those who have 
researched this problem have looked at developmental effects on neonates into childhood using a 
retrospective cohort study (n=6,841; Warshak, Regan, Moore, Magner, Kritzer, & Van Hook, 
2015) and a secondary analysis of randomized-controlled trial (n=1867; Dotters-Katz, Smid, 
Manuck, & Metz, 2017).  Researchers have studied the neonatal adverse outcomes of preterm 
delivery (Warshak et al., 2015), preeclampsia (Warshak et al., 2015), gestational diabetes 
(Warshak et al., 2015), cesarean delivery (Warshak et al., 2015), fetal growth restriction 
(Warshak et al., 2015), perinatal mortality (Warshak et al., 2015), childhood and neonatal 
morbidity (Dotters-Katz, Smid, Manuck, & Metz, 2017), periventricular leukomalacia (Dotters-
Katz, Smid, Manuck, & Metz, 2017), and bronchopulmonary dysplasia (Dotters-Katz, Smid, 
Manuck, & Metz, 2017).  In general, researchers found no increased risk of severe negative 
obstetrical outcomes in newborns with the use of marijuana use during pregnancy (Warshak et 
al., 2015).  In a secondary analysis, researchers found that in a sample of 1867, 138 (7.2%) were 
exposed to marijuana use during pregnancy (Dotters-Katz, Smid, Manuck, & Metz, 2017); no 
differences were noted in neonatal or childhood outcomes in unexposed marijuana pregnancies 
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versus pregnancies exposed to marijuana.  Future researchers should continue studying 
prevalence and effects of marijuana use in pregnant women on these and other longer-term 
outcomes.   
Nursing interventions.  As previously mentioned, despite repeated search efforts, only 
one intervention study of pregnant women using marijuana was found.  This may be due to 
polysubstance abuse rather than solely marijuana abuse in pregnant women.  Increase in research 
to study the effects of marijuana through intervention studies is anticipated as legalization of 
marijuana increases in the United States.  Gray, Beatty, Svikis, Puder, Resnicow, Konkel, & 
Ondersma (2017) studied the effects of motivational interviewing (MI) techniques through 
electronic brief messaging and found that MI was effective in this population.  Using a small 
sample of ten pregnant women, the researchers found that 9 out of 10 women reported that the 
intervention caused them to be more likely to decrease their marijuana use during 
pregnancy.  Overall, more research is needed involving non-pharmacological interventions for 
mothers and neonates affected by marijuana use as it becomes more prevalent in healthcare in 
the future.  
Critical Appraisal of Evidence 
Limitations.  Although there is accuracy of this systematic review, it is not without limitations. 
A limitation of this review is the lack of articles provided; specifically, information found 
regarding the use of marijuana during pregnancy.  Twenty journals were reviewed and 
compared.  There was limited research found on the nonpharmacologic interventions used on 
mothers abusing marijuana during pregnancy.  Also, information was not limited to studies 
inside the United States.  Two studies were used from Denmark (Nørgaard, Nielsson, & Heide-
Jørgensen, 2015) and South Africa (Lubbe, Walbeek, & Vellios, 2017) to support this systematic 
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review.  Journals were searched with CINAHL and PubMed but some valuable journals found 
were required to be purchased. This is a limitation in the review. Findings of the review may be 
limited due to the fact only published and readily available journals were used. Journals were 
searched back to 2012 in order to find at least 20 published writings.  This limitation could alter 
the information as to be outdated. Since this review group had a total of four (4) researchers, it is 
appropriate to speculate that while searching for relevant articles, personal bias or opinions on 
certain studies could have been present. It is correct to assume every researcher is different in the 
selection of consistent articles.  
Reliability & Validity. The most common design method that was found was retrospective 
cohort (Warshak et al., 2015; Mark, Desai, & Terplan et al., 2015; Howard et al., 2017; Krans et 
al., 2018; Patrick et al., 2018; Nørgaard, Nielsson, & Heide-Jørgensen, 2015).  In a retrospective 
cohort, researchers investigate past studies or occurrences to determine possible causative 
factors.  Limitations of this type of design include that they are viewing this information after the 
actual event of recording and that the researchers cannot definitively say that the independent 
variable caused the dependent variable.  Therefore, all conclusions are based in probability and 
likelihood.  
Randomized control trial (Dotters-Katz, Smid, Manuck, & Metz, 2017; Lander et al., 
2015; Osterman et al., 2014; Rendall-Mkosi et al., 2012; Kaner et al., 2013) is a method design 
where participants are assigned to either an interventional group or control group.  This type of 
design is performed in a controlled setting, targeting a specific nursing intervention, and has a 
measurable outcome. Limitations to this type of design include participation bias, being that the 
volunteered participants may not be a correct representation of the targeted population as a  
whole.  
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 Another methodology used was cross-sectional design (Savory, Couves, & Burns, 2014; 
May et al., 2018; Coleman-Cowger, Oga, Peters, & Mark, 2018; Metz, Brown, Martins, & 
Palamar, 2017).  Cross-sectional design uses observation to compare the results of different 
participants at the same time.  Advantages of this design include that researchers can compare 
outcomes quickly and that readers get information on prevalence of outcomes and/or exposure. 
They are especially helpful in establishing a baseline in cohort studies and in planning cohort 
studies.  However, no design is perfect, and the cross-sectional design is no exception.  
 The next design methods that will be discussed were seen less than the prior design 
methods.  A case study design was observed (Lubbe, Walbeek, & Vellios, 2017).  In this type of 
design researchers focus on a single patient or community.  Detailing diagnosis, nursing care, 
and environmental factors.  In this type of method, researchers directly observe their subject.  A 
great limitation to this type of method is the small amount of data it collects specifically on one 
patient or community, causing it to be less reliable than others.  Another design method used was 
prospective cohort (Bakhirva et al., 2018).  A prospective cohort study is a longitudinal cohort 
study that follows a group of individuals over time, often for years, to determine how different 
factors affect rates of outcomes.  Relative to the other observational study designs, prospective 
cohort studies hold the strongest level of evidence.  Advantages of this design include the 
extended length of the observation.  Researchers are able to collect more evidence regarding 
their subject of study and possibly discover data that would not have been found had the study 
been for only weeks as compared to years. 
Another design method used was quasi-experimental (Andrews et al., 2018).  Quasi-
experimental studies are similar to experimental design studies with the exception of using a 
non-randomized cohort.  This means that is weaker than the standard experimental study but is 
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more reasonable to complete in a healthcare study.  While quasi-experimental studies are 
weaker, they provide a good starting point to see the beginning of causality.  Another design 
method used was logistic regression analysis (Angelotta, Weiss, Angelotta, & Friedman, 2016). 
This method is used to estimate a data value based on past observations of a data set.  It 
examines the link between one or more present independent variables whilst predicting a 
dependent variable.  A limitation to this specific method is it is unable to predict continuous 
outcomes.  
The design methods and findings of the studies are reliable due to the fact that most of 
the studies analyzed showed similar results. A majority of these studies showed negative 
outcomes between using marijuana, opioids, or alcohol during pregnancy as well as provided 
more information on neonate and mother outcome while using these illicit substances (Angelotta 
et al., 2016; Nørgaard, Nielsson, & Heide-Jørgensen, 2015; Andrews et al., 2018; Kaner et al., 
2013;  Rendall-Mkosi et al., 2012; Osterman et al., 2014; Lander et al., 2015; Lubbe, Walbeek, 
& Vellios, 2017; Patrick et al., 2018; Krans et al., 2018; Howard et al., 2017; Mark, Desai, & 
Terplan et al., 2015; Bakhirva et al., 2018; Warshak et al., 2015; Metz, Brown, Martins, & 
Palamar, 2017; May et al., 2018; Savory, Couves, & Burns, 2014). Only one study showed no 
negative effect on neonate or mother outcome on use of marijuana during pregnancy (Dotters-
Katz, Smid, Manuck, & Metz, 2017). Overall, all studies evaluated have shown a need for 
attention and further research in this area.  
Savory and colleagues (2013) surveyed pregnant women to report their amount of drinks 
of alcohol per day consumed.  The study did not specify what the term “drink” meant.  This 
meaning, what one participant would consider moderate consumption of alcohol could be what 
another participant considers excessive . Therefore, this could skew the results on the exact 
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amount of alcohol consumption during pregnancy (Savory et al., 2013).  Similar limitations 
across studies included social desirability and personal bias.  These studies speculated that their 
subjects may have lied about marijuana, alcohol, and opioid use during pregnancy due to fear of 
being stigmatized and looked down upon by the researchers or peers (Bakhireva et al., 2018; 
Mark., Desai, & Terplan, 2015; Metz, Brown, Martins, & Palamar, 2017; and Rendall-Mkosi et 
al., 2012).  Research bias was a similar limitation found across studies.  Some studies only 
included non-institutionalized pregnant woman, causing an underrepresentation of the population 
(Metz, Brown, Martins, & Palamar, 2017).  Small sample sizes lead to lack of generalization of 
the data found in the studies and is common in health care studies due to not enough resources or 
time for a study with a large number of participants to take place (May et al., 2018; Howard et 
al., 2017).  Due to the large number of retrospective cohort studies, errors of omission and 
commission were also common (Warshak et al., 2015; Mark, Desai, & Terplan et al., 2015; 
Howard et al., 2017; Krans et al., 2018; Patrick et al., 2018; Nørgaard, Nielsson, & Heide-
Jørgensen, 2015).  Errors of omission means the information that was gathered from the past in 
the retrospective cohort may have been left out.  In comparison, errors of commission means that 
the information available may have been put in incorrectly. This causes a mishap in data 
collection as a whole.  
       Synthesis of Evidence 
The results of this systematic review is that eight (8) of the articles involved focused on 
opioid abuse during pregnancy, eight (8) of the articles involved focused on alcohol abuse during 
pregnancy, and four (4) articles involved focused on marijuana use during pregnancy. 
The most effective interventions for mothers and their neonates affected by opioid abuse 
included treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018; 
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Lander et al., 2015), prevention of relapse (Andrews et al., 2018; Krands et al., 2018; Lander et 
al., 2015),  maintaining healthy mother-child relationships (Andrews et al., 2018; Krans et al., 
2018; Howard et al., 2017), and patient education (Andrews et al., 2018; Howard et al., 2017). 
Other individual intervention that was found to be beneficial for neonates was 100% parental 
presence at bedside due to the increased frequency of breastfeeding and mother-child bonding 
that decreased the mean NAS score (Howard et al. 2017).  Regarding alcohol use during 
pregnancy, motivational interviewing proved to be a significant intervention (Osterman et al., 
2014; Rendall-Mkosi et al., 2012).  Motivational interviewing was also used in the one article 
found on non-pharmacological interventions regarding marijuana use during pregnancy (Gray et 
al., 2017). This type of non-pharmacological intervention proved to be effective in clinical 
practice.    
Recommendations 
 This systematic review looked at 20 different studies generating a wide array of results 
regarding drug abuse during pregnancy.  After review, the researchers formulated 
recommendations for future clinical use.  Overall, more research regarding maternal use of illicit 
substances during pregnancy needs done and non-pharmacological interventions involving.  
Specifically, more research is needed in the area of marijuana use during pregnancy as only three 
relevant studies were found.  This is important to future research and public health due to the 
legalization of marijuana in some U.S. states.  
Based on current research done that is supported by this systematic review, Motivational 
Interviewing (Osterman, Carle, Ammerman, & Gates, 2014; Rendall-Mkosi, Morojele, London, 
Moodley, Singh, & Girdler-Brown, 2012) seemed to be the most effective intervention when 
aiding pregnant women addicted to marijuana or alcohol during pregnancy.  This intervention 
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proved to be the most researched and most effective for these addictions.  Since this intervention 
proved to be the most research, recommendations for different interventions are encouraged.  
As for non-pharmacological interventions involved specialized comprehensive care that 
included treatment of addiction (Andrews et al., 2018; Howard et al., 2017; Krans et al., 2018; 
Lander et al., 2015), prevention of relapse (Andrews et al., 2018; Krands et al., 2018; Lander et 
al., 2015), patient education (Andrews et al., 2018; Howard et al., 2017), and maintaining healthy 
mother-child relationships (Andrews et al., 2018; Krans et al., 2018; Howard et al., 2017). This is 
best accomplished through coordinated, multidisciplinary care (Andrews et al., 2018). Providing 
this type of care is a complex and lengthy process to maximums efficiency in treating mothers 
and their neonates.  Because of the complexity, the more research done on honing the process of 
providing comprehensive care for mother’s with opioid abuse disorder and their neonates, the 
better.  
Other recommendations for future clinical use is to provide more resources and non-
pharmacological interventions for women addicted to marijuana, opioids, and alcohol. 
Researchers found it difficult to find relevant intervention studies regarding only non-
pharmacological interventions.  Pharmacological interventions came in abundance even when 
looking for non-pharmacological interventions.  Clinical practices should be evaluating non-
pharmacological interventions as well to assist women in their addiction.  
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 Systematic Review Table of Evidence 
APA formatted 
reference 
Purpose 
statement. 
Research 
question.  
Clinical Practice 
Setting, Sampling 
methods, Sample 
size.  
Design. Level 
of Evidence.  
Findings, Conclusion Practice & Research 
Implications 
Limitations of Findings 
Andrews, N. C., 
Motz, M., Pepler, 
D. J., Jeong, J. J., 
& Khoury, J. 
(2018). Engaging 
mothers with 
substance use 
issues and their 
children in early 
intervention: 
Understanding 
use of service and 
outcomes. Child 
Abuse & Neglect, 
83, 10-20. 
doi:10.1016/j.chia
bu.2018.06.011 
Purpose 
statement:” to 1) 
describe women’s 
use of service, 2) 
examine how 
early 
engagement of 
pregnant women 
related to 
postnatal service 
use, and 3) 
examine the 
circum- 
stances in which 
women ended 
their service 
relationship with 
Breaking the 
Cycle” (p. 1). 
 
Research 
question: How 
does Breaking the 
Cycle help the 
gap between the 
relationship of 
mother and child 
that is lacking, 
“by providing not 
Setting: Toronto, 
Canada 
Sampling methods: 
All mothers were 
asked during the 
intake process at 
BTC. 
Sample size: Out 
of 168 women who 
consented to 
participate, 160 
were enrolled. 
 
 
Design: quasi 
experimental 
 
Level of 
evidence: Level 
III 
Findings:  “...time in service 
is generally associated with 
better outcomes and 
highlights the success of 
long-term engagement in 
integrated, relationships-
focused service for mothers 
with substance use issues 
and their children” (p. 10). 
 
Conclusion: “...participating 
in service at BTC relates to 
increased relationship 
capacity and improved 
mental health functioning” 
(p. 10). 
 
Practice and Research 
Implication: “...consider the 
implications of a relational 
approach to health service 
provision, and the additional 
resources and supports that 
may be necessary to enable 
service providers to 
implement these essential 
services” (p. 10). 
 
Limitations: Available 
information varied 
across participants, due 
to different use of 
service and length of 
involvement 
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only instrumental 
and substance use 
support for 
mothers with 
substance use 
issues, but also 
focus on 
strengthening and 
promoting the 
mother child 
relationship?” (p. 
2). 
Angelotta, C., 
Weiss, C. J., 
Angelotta, J. W., 
& Friedman, R. 
A. (2016). A 
Moral or Medical 
Problem? The 
Relationship 
between Legal 
Penalties and 
Treatment 
Practices for 
Opioid Use 
Disorders in 
Pregnant Women. 
Women’s Health 
Issues, 26(6), 
595-601. 
doi:10.1016/j.whi.
2016.09.002 
 
Purpose 
statement: 
To describe the 
“...relationship 
between use of 
medication-
assisted treatment 
(MAT) in 
pregnant women 
with opioid use 
disorders, the 
standard of care, 
and state laws that 
permit child abuse 
charges for illicit 
drug use during 
pregnancy” (p.1). 
 
Setting: USA 2012 
Sampling method: 
“Using publicly 
available data on 
substance abuse 
treatment in the 
United States, we 
describe patterns in 
the use of MAT for 
pregnant women 
with opioid use 
disorders in states 
with prenatal child 
abuse laws 
compared with 
states without such 
laws” (p.1) 
Sample Size: 
“In 2012, there 
were 8,292 
treatment episodes 
of pregnant women 
with a primary 
opioid use disorder 
in the United 
Design: Meta-
analysis 
Level of 
Evidence: 
Level VI 
Findings: 
“In 2012, there were 8,292 
treatment episodes of 
pregnant women with a 
primary opioid use disorder 
in the United States for 
which data on MAT use 
were available. Among 
states with laws that permit 
child abuse charges for 
illicit drug use in pregnancy 
(18 states), MAT was used 
in 33.15% of treatment 
admissions compared with 
51.33% of admissions in 
states without a law” (p.1). 
practice & Research 
Implications: “Limitations of 
the study include the low 
number of participants who 
actually completed the study 
(only half of those 
consented), therefore limiting 
our ability to determine 
statistical significance among 
our primary dependent 
variables of retention and 
relapse rates. In addition, the 
explicit content of the 
OBGYN-affiliated providers’ 
group discussion was not 
structured, nor were 
satisfaction ratings 
administered specific to these 
group sessions. Perhaps if 
this portion of the 
intervention were more 
prescribed it would have 
added to the efficacy of the 
intervention, and the impact 
could have been more 
Limitations of Findings: 
Women may be reluctant 
to admit to opioid use 
because of the legal 
implications. 
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States for which 
data on MAT use 
were available in 
TEDS-A. The 
majority of the 
treatment episodes 
were of women 
who were age 18 to 
29 (71.93%; n ¼ 
5,965), White 
(85.01%; n ¼ 
7,049), and not 
married (72.26%; n 
¼ 5,992)”   (p. 4) 
explicitly measured and 
replicated” (p .6). 
Bakhireva, L.N., 
Shrestha, S., 
Garrison, L., 
Leeman, L., 
Rayburn, W.F., & 
Stephen, J.M. 
(2018). 
Prevalence of 
alcohol use in 
pregnant women 
with substance 
use disorder. 
Drug and Alcohol 
Dependence.  
Purpose 
Statement: 
“This study 
evaluated self-
reported 
prevalence of 
alcohol use in 
patients 
participating in a 
comprehensive 
prenatal care 
program for 
women with 
substance use 
disorder” (p. 1). 
 
Research 
Question: Is there 
a prevalence of 
alcohol use in 
pregnant women 
with substance 
use disorder?  
Setting: Prenatal 
care program for 
women with 
substance use 
disorder, and 
pregnant women at 
general clinics at 
the University of 
New Mexico 
before conception 
periods and 
between the last 
menstrual period 
and pregnancy 
recognition. 
 
Sampling method: 
Conducted in six 
prenatal care 
clinics associated 
with the UNM 
departments of 
Design: 
evaluated self- 
reported of 
alcohol usage.  
This study 
evaluated self-
reported 
prevalence of 
alcohol use in 
patients 
participating in 
a 
comprehensive 
prenatal care 
program for 
women with 
substance use 
disorder (SUD; 
n = 295), of 
which 95% are 
treated for 
OUD, and 
pregnant 
Findings: Alcohol 
consumption was higher in 
patients screened at the 
specialty clinic for pregnant 
women with SUD. 15% of 
pregnant women in general 
obstetrics and SUD patients 
consume at least 3 
drinks/week on average.  
 
Conclusions: This study 
demonstrates a high 
prevalence of prenatal 
alcohol use in early 
pregnancy in both groups, 
while patients with 
SUD/OUD consume more 
alcohol. These findings 
underscore the need for 
targeted screening and 
intervention for alcohol use 
in all pregnant women, 
Findings & Research 
implications: To minimize 
participation bias, all 
pregnant women attending a 
scheduled prenatal visit on 
days when a study 
coordinator was present at 
the clinic were offered 
screening for the study. First 
study using a large U.S. 
sample of pregnant women to 
characterize periconceptional 
and early pregnancy alcohol 
use behaviors among women 
in a comprehensive treatment 
program for SUD (Mostly 
SUD) 
Limitation of Findings: 
Prevalence might be an 
underestimation; 
information was 
obtained from the 
screening stage of the 
ENRICH study. They 
can’t report changes in 
alcohol usage later in 
pregnancy. , cannot 
report the exact number 
of subjects with OUD 
among MILARGO 
points who participated 
in the screening since 
questions about illicit 
drug use were not asked 
at the screening stage 
due to sensitivity, the 
general obstetric group 
was recruited mostly 
from low risk clinics. .  
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OB/GYN or 
Family Medicine.  
 
Sampling Size: 
Large number of 
Hispanic/Latino 
participants. 97 
(26.6%) from 
general obstetrics 
group and 74 
(25.1%) patients 
with SUD were 
classified as 
binge/chronic 
moderate alcohol 
users.  
women being 
served through 
general 
obstetrical 
clinics at the 
University of 
New Mexico (n 
= 365). During 
the screening 
phase of a 
prospective 
study, patients 
were asked to 
report alcohol 
use in the 
periconceptiona
l period, and 
between the last 
menstrual 
period and 
pregnancy 
recognition. 
Results: The 
screening 
interview was 
conducted at 
22.3 (median = 
22; Q1 = 16; 
Q3 = 29) 
gestational 
weeks. Among 
patients 
screened at the 
SUD clinic, 
28.8% and 
24.1% reported 
at least one 
especially those with 
SUD/OUD 
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binge drinking 
episode in the 
periconceptiona
l period and in 
early 
pregnancy, 
respectively. 
The prevalence 
of binge 
drinking was 
similar in the 
general 
obstetrics 
population 
(24.7% and 
24.4%, 
respectively). 
Among those 
who reported 
drinking in 
early 
pregnancy, 
median number 
of binge 
drinking 
episodes was 
higher among 
patients 
screened at the 
SUD clinic 
(median = 3; 
Q1 = 1; Q3 = 
10) compared 
to the general 
obstetrics group 
(median = 1; 
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Q1 = 1; Q3 = 3; 
p < 0.001) 
 
Level of 
Evidence: IV  
Coleman-Cowger, 
V. H., Oga, E. A., 
Peters, E. N., & 
Mark, K. (2018). 
birth outcomes of 
co-use of 
Cannabis and 
tobacco cigarettes 
during pregnancy. 
Neurotoxicology 
and Teratology, 
68, 84-90. 
doi:10.1016/j.ntt.
2018.06.001 
Purpose 
Statement: “The 
purpose of this 
study is to: 1) 
describe the 
prevalence of co-
use of Cannabis 
and tobacco 
cigarettes 
reported by a 
convenience 
sample of 
pregnant women 
presenting to two 
urban prenatal 
clinics; 2) outline 
correlates of co-
use of Cannabis 
and tobacco 
cigarettes; and 3) 
compare birth 
outcomes 
between pregnant 
women who co-
use Cannabis and 
tobacco 
cigarettes, who 
currently smoke 
tobacco cigarettes 
but do not use 
Cannabis, who 
currently use 
Setting: Two 
University 
obstetric clinics in 
Maryland from 
January to 
December 2017. 
Sampling Method: 
“Pregnant women 
were enrolled in 
the study if they 
met the following 
criteria: 1) 
currently pregnant; 
2) age 18 years or 
older; 3) able to 
speak and 
understand English 
sufficiently to 
provide informed 
consent; and 4) 
natural hair length 
at least 3cm to 
allow for drug 
testing” (p. 2). 
Sample Size: 1170 
pregnant women 
were questioned in 
regard to this study 
at both clinics, 719 
were eligible, and 
500 were included.  
 
Design: Quasi-
experimental 
 
Level of 
Evidence: 
Level III 
 
Findings: “The prevalence 
rate of Cannabis and 
tobacco cigarette co-use as 
well as the prevalence rate 
of Cannabis only use is 
higher than the prevalence 
of tobacco cigarette only 
use, which is notable given 
the focus on tobacco 
cessation in clinical 
practice” (p. 5).  Second, an 
association was found 
between co-use and smaller 
head circumference, but 
there was no correlation 
between Cannabis use and 
low birth weight. 
 
Conclusion: “The 
examination of Cannabis 
and tobacco co-use during 
pregnancy among 
marginalized, vulnerable 
populations with relatively 
high use prevalence is a 
highly significant endeavor, 
particularly as Cannabis 
use, its potency, and 
availability in the US have 
increased in recent years. 
Additional research is 
needed to better understand 
Practice & Research 
Implications: Recommended 
that a screening tool be 
created for pregnant women 
who use Cannabis, a greater 
focus on health implications 
is needed. 
 
Limitations of Findings: 
No randomized group 
assignment (subjects 
were already pregnant 
and not for the sake of 
the study); more 
correlation and not prove 
causation 
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Cannabis but do 
not smoke 
tobacco 
cigarettes, and 
who do not 
currently use 
Cannabis or 
tobacco 
cigarettes” (p. 2). 
 
Research 
question: How do 
tobacco and 
Cannabis interact 
synergistically to 
influence birth 
outcomes? 
 
how factors such as 
potency, reasons for use, 
modes of use, trimester of 
exposure, and 
contextual/environmental 
cues may moderate the 
relationship between co-use 
and health outcomes for 
both mother and child” (p. 
6).  
 
Dotters-Katz, 
S.K., Smid, M.C., 
Manuck, T.A., & 
Metz, T.D. 
(2017). Risk of 
neonatal and 
childhood 
morbidity among 
preterm infants 
exposed to 
marijuana. 
Journal of 
Maternal Fetal 
Neonatal 
Medicine. 30(24). 
 
 
 
Purpose 
Statement:  
“We hypothesized 
that MJ-exposed 
preterm infants 
would have worse 
neonatal and 
childhood 
developmental 
outcomes 
compared to MJ-
unexposed 
infants.” (p. 1.) 
 
Research 
Question: What is 
the risk of 
neonatal and 
childhood 
Setting: 20 
institutions around 
the United States 
from 1997-2004 
 
Sampling Method: 
Criteria: 
gestational age at 
35 weeks was 
selected. Excluded 
twin gestations, 
infants with major 
congenital 
anomalies, and 
those infants who 
delivered after 34 
weeks and 6 days 
of gestation.   
 . 
Design: 
Secondary 
analysis of a 
multicenter 
randomized 
controlled trial  
 
Level of 
Evidence: I 
 
 
Findings: 135 (7.2%) were 
marijuana exposed. No 
differences in neonatal or 
childhood outcomes in 
marijuana exposed infants 
compared to marijuana 
unexposed infants. 
 
Conclusion: Among infants 
born less weeks of gestation 
marijuana exposure was not 
associated with adverse 
neonatal or childhood 
outcomes. Long term follow 
up studies are needed to 
assess later childhood 
neurodevelopmental 
outcomes following 
marijuana exposure. 
Practice and Research 
Implications: Data was from 
a large prospective 
randomized controlled trial. 
Childhood 
neurodevelopmental 
outcomes were collected by 
trained pediatricians or 
pediatric neurologists. Data 
from this study was collected 
at 20 centers across the 
United States and represent 
an ethnic makeup similar to 
the general population; 
makes the findings more 
generalizable.  
 
Limitations: 
Inability to assess the 
frequency or timing of 
marijuana use during 
pregnancy. No human 
data regarding the fetal 
effects of marijuana 
based on trimester of 
exposure. They did not 
have urine drug screen 
results on all women; 
use may be 
underreported. Majority 
of babies in these studies 
were delivered following 
PPROM, an obstetric 
complication 
traditionally associated 
with high rates of 
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morbidity among 
preterm infants 
exposed to 
marijuana?  
Sample Size: 
n=1867 infants 
 
neonatal and childhood 
morbidity and mortality 
due to an increased 
likelihood of infectious 
morbidity.    
Gray, J., Beatty, J. 
R., Svikis, D. S., 
Puder, K. S., 
Resnicow, K., 
Konkel, J., … 
Ondersma, S. J. 
(2017). Electronic 
Brief Intervention 
and Text 
Messaging for 
Marijuana Use 
During 
Pregnancy: Initial 
Acceptability of 
Patients and 
Providers. JMIR 
Mhealth And 
Uhealth, 5(11), 
e172. 
https://doi.org/10.
2196/mhealth.792
7 
 
Purpose 
Statement: 
“The objective of 
the study was to 
evaluate, among 
pregnant women 
and prenatal care 
providers, the 
acceptability of an 
electronic brief 
intervention and 
text messaging 
plan for marijuana 
use in pregnancy” 
(p.1). 
 
 
Research 
question:  
“How acceptable 
is electronic brief 
intervention and 
text messaging 
plan for marijuana 
use in pregnancy 
to pregnant 
women and 
prenatal care 
providers? 
Setting: a prenatal 
clinic in Detroit, 
Michigan  
 
Sampling Method: 
Patient participants 
women recruited 
from a prenatal 
clinic in Detroit, 
Michigan. 
Inclusion criteria 
were self-report of 
marijuana use at 
least twice weekly 
in the month 
before pregnancy, 
aged between 18 
and 40 years, less 
than 20 weeks 
pregnant, and 
owning a cellphone 
(As participants 
would be 
responsible for any 
charges resulting 
from receiving text 
messages on their 
personal phone, all 
participants were 
specifically asked 
their willingness to 
receive text 
Design:  
“Participants 
included 
patients (n=10) 
and medical 
staff (n=12) 
from an urban 
prenatal clinic. 
Patient-
participants 
were recruited 
directly during 
a prenatal care 
visit. Those 
who were 
eligible 
reviewed the 
interventions 
individually 
and provided 
quantitative and 
qualitative 
feedback 
regarding 
software 
acceptability 
and helpfulness 
during a one-
on-one 
interview with 
research staff. 
Provider-
“Patient-participants 
provided high ratings for 
satisfaction, with mean 
ratings for respectfulness, 
interest, ease of use, and 
helpfulness ranging between 
4.4 and 4.7 on a 5-point 
Likert scale. Of the 10 
participants, 5 reported that 
they preferred working with 
the program versus their 
doctor, and 9 of 10 said the 
intervention made them 
more likely to reduce their 
marijuana use. Provider-
participants received the 
program favorably, stating 
the information presented 
was both relevant and 
important for their patient 
population.” 
“These findings suggest that 
the women in this study were 
open to examining their 
marijuana use during 
pregnancy and to doing so 
via technology. Participants 
were happy with the 
unbiased presentation of the 
effects of marijuana on the 
baby, found the materials 
useful and easy to use, and 
clearly spent time evaluating 
whether or not they should 
stop use during pregnancy.” 
This study is limited by 
its relatively small 
sample size of all 
African American 
women from a clinic in 
the urban Detroit area. 
However, Their aim was 
not to conduct a fully 
powered test of an a 
priori hypothesis, but 
rather to provide 
information regarding 
participant acceptability 
and usability, which 
typically involves 
smaller sample sizes. 
Additionally, it may 
have been preferable to 
present text messages for 
feedback as a 
presentation where each 
text message could be 
looked at separately. 
Having a single 
document with a sample 
of each week's messages 
was overwhelming for 
some participants. 
Future studies should 
also consider ways to 
tailor the text messages 
for the participants 
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messages during a 
feedback 
interview.). 
Exclusion criteria 
included inability 
to understand 
English, inability 
to provide consent, 
consideration of an 
elective abortion or 
adoption for the 
current pregnancy, 
or past 
participation in any 
other study by the 
authors. 
Provider-
Participants of the 
medical staff from 
the same prenatal 
clinic, members 
volunteered to 
participate in focus 
groups regarding 
the intervention 
materials. We 
offered 
participation to all 
physicians in the 
department;  
physicians were 
available to attend 
one focus group, 
and medical staff 
(all of the nurses, 
medical assistants, 
and reception staff 
participants 
took part in 
focus groups in 
which the 
intervention 
materials were 
reviewed and 
discussed. 
Qualitative and 
focus group 
feedback was 
transcribed, 
coded 
manually, and 
classified by 
category and 
theme.” 
providing feedback. This 
study was only able to 
show examples and 
describe how messages 
would be tailored and 
may have missed 
valuable feedback 
because of the 
presentation format.” 
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from the clinic 
where recruitment 
took place) 
participated in the 
second focus 
group. 
 
Howard, M. B., 
Schiff, D. M., 
Penwill, N., Si, 
W., Rai, A., 
Wolfgang, T., 
Wachman, E. M. 
(2017). Impact of 
Parental Presence 
at Infants’ 
Bedside on 
Neonatal 
Abstinence 
Syndrome. 
Hospital 
Pediatrics. 
doi:10.1542/hped
s.2016-0147 
Purpose 
statement: “to 
examine the effect 
of the amount of 
parental presence 
at the bedside on 
NAS severity; 
specifically, the 
association with 3 
main outcomes: 
(1) hospital LOS, 
(2) extent of 
pharmacologic 
therapy required, 
and (3) mean 
Finnegan 
withdrawal 
scores” (p. 2). 
Research 
question: 
“examine the 
association 
between rates of 
parental presence 
and NAS 
outcomes” (p. 2). 
Setting: Infants 
born at Boston 
Medical Center 
between March 
2015-April 2016 
with opioid 
exposure prior to 
birth. 
Sampling methods: 
Subjects were 
considered eligible 
to participate in the 
study if: “maternal 
opioid agonist 
treatment with 
methadone or 
buprenorphine 
during the third 
trimester of 
pregnancy and 
infants with a 
gestational age >36 
weeks treated with 
opioid replacement 
therapy for opioid 
withdrawal on a 
pediatric inpatient 
unit” (p. 2). 
Design: quasi 
experimental; 
“retrospective, 
single-center 
cohort study of 
infants treated 
pharmacologica
lly for NAS 
using a 
rooming-in 
model of care” 
(p. 1). 
 
Level of 
Evidence: 
Level III 
Findings: Breastfeeding was 
associated with decreased 
LOS. However, infants who 
were breastfed had a higher 
percentage of parental 
presence. “Across the 
cohort, the mean NAS score 
when a parent was present 
was significantly lower 
compared with when a 
parent was not present” (p. 
4). 
 
Conclusion: Study supports 
the role of rooming-in and 
parental engagement in 
infant care for decreasing 
withdrawal severity, LOS, 
and pharmacological 
treatment of infants with 
NAS” (p. 6). Breastfeeding 
should be encouraged in 
order to decrease LOS and 
increase parental 
involvement. 
Practice and Research 
Implications: Focus on 
parental presence to promote 
breastfeeding, skin-to-skin 
time, and parental-infant 
bonding. Additional research 
is needed to explore support 
programs to help eliminate 
the barriers to parental 
presence; specifically, “…the 
stigma and guilt experienced 
by women with substance 
use disorders watching their 
infants go through 
withdrawal” (p. 5). 
 
Limitations: small 
sample size, how they 
measured parental 
presence (new metric for 
nurses to chart) 
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Sample size: Out 
of 138 infants with 
in-utero exposure, 
only 86 were 
selected to be 
included in the 
study cohort. 
Kaner, E., Bland, 
M., Cassidy, P., 
Coulton, S., Dale, 
V., Deuca, P., 
Gilvarry, E., 
Godfrey, C., 
Heather, N., 
Myles, J., 
Newbury-Birch, 
D., Oyefeso, A., 
Parrott, S., 
Perryman, K., 
Phillips, T.,  
Shepherd, J. & 
Drummond, C. 
(2013) 
Effectiveness of 
screening and 
brief alcohol 
intervention in 
primary care 
(SIPS trial): 
pragmatic cluster 
randomized 
controlled trial. 
BMJ 346, 8501. 
doi: 
https://doi.org/10.
1136/bmj.e8501 
Purpose 
Statement & 
Research 
Question 
Research 
Question: What is 
the effectiveness 
of screening and 
brief alcohol 
intervention in 
pregnant women?  
Purpose 
Statement: To 
evaluate the 
effectiveness of 
different brief 
intervention 
strategies at 
reducing 
hazardous or 
harmful drinking 
in primary care. 
Setting: Primary 
care practices in 
the north east and 
southeast of 
England and in 
London 
Sampling 
Methods: 3562 
patients aged 18 or 
more routinely 
presenting in 
primary care of 
whom 2991 (84%) 
were eligible to 
enter the trial: 900 
(30.1%) screened 
positive for 
hazardous or 
harmful drinking 
and 756 (84%) 
received a brief 
intervention. The 
sample was 
predominantly 
male (62%) and 
white (92%) and 
34% were current 
smokers. 
Sample Size: 3562 
Design: 
Practices were 
randomized to 
three 
interventions, 
each of which 
built on the 
previous one: a 
patient 
information 
leaflet control 
group, five 
minutes of 
structured brief 
advice, and 20 
minutes of brief 
lifestyle 
counselling. 
Delivery of the 
patient leaflet 
and brief advice 
occurred 
directly after 
screening and 
brief lifestyle 
counselling in a 
subsequent 
consultation. 
Pragmatic 
cluster 
Findings: Patient follow-up 
rates were 83% at six 
months (n=644) and 79% at 
12 months (n=617). At both 
time points an intention to 
treat analysis found no 
significant differences in 
AUDIT negative status 
between the three 
interventions. Compared 
with the patient information 
leaflet group, the odds ratio 
of having a negative 
AUDIT result for brief 
advice was 0.85 (95% 
confidence interval 0.52 to 
1.39) and for brief lifestyle 
counselling was 0.78 (0.48 
to 1.25). A per protocol 
analysis confirmed these 
findings 
Conclusions: All patients 
received simple feedback on 
their screening outcome. 
Beyond this input, however, 
evidence that brief advice or 
brief lifestyle counselling 
provided important 
additional benefit in 
reducing hazardous or 
Practice and Research 
Implications: This research 
provided good information 
for future research. It would 
be beneficial to look into the 
specific aspects of brief 
intervention to see which part 
makes an impact. Research 
into how women receive 
brief interventions would 
allow insight into why it is 
effective.  
Limitation of Findings: 
Inability to initiate more 
intense brief 
intervention. Lack of 
previous research to 
build off.  
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patients 
 
randomized 
controlled trial 
Level of 
Evidence: 
Level III 
harmful drinking compared 
with the patient information 
leaflet was lacking. 
Krans, E.E., 
Bobby, S., 
England, M., 
Gedekoh, R.H., 
Chang, J.C., 
Maguire, 
B.,...English, 
D.H. (2018). The 
pregnancy 
recovery center: 
A women-
centered 
treatment 
program from 
pregnant and 
postpartum 
women with 
opioid use 
disorder. 
Addictive 
Behaviors 
 
Purpose 
statement: “is to 
a) evaluate the 
impact of women-
centered services 
on 
outcomes among 
pregnant and 
postpartum 
women with OUD 
and b) 
provide a 
programmatic 
description of 
women-centered 
services that 
can be used to 
inform the clinical 
protocols of 
treatment 
programs that 
care for women 
with OUD” (p. 2). 
 
Research 
question: Does a 
women-centered 
treatment 
program for 
pregnant and 
postpartum 
women with 
Setting: Magee-
Women’s Hospital 
between July 2014 
and 2016 
 
Sampling methods: 
Among 643 
women who gave 
birth at this 
hospital, 248 were 
using 
buprenorphine. 71 
enrolled in PRC 
and 177 were 
enrolled in a non-
PRC 
buprenorphine 
treatment program 
Sample size: 248 
pregnant women 
with OUD  
Design: 
comparison of 
two 
retrospective 
cohorts 
 
Level of 
Evidence: 
Level IV 
Findings: Pregnancy 
Recovery Center patients 
“had significant 
improvement in pregnancy-
specific MAT dosing, 
postpartum visit attendance, 
breastfeeding continuation 
rates and postpartum LARC 
use” (p. 5). 
 
Conclusion: “Incorporating 
women-centered services 
into OUD treatment 
programming may improve 
gender-specific outcomes 
among women with OUD” 
(p. 1). 
Practice and Research 
Implications: Further 
research is needed to address 
the unique needs of pregnant 
and postpartum women to 
improve the health of women 
with OUD and their children 
Limitations: difficult to 
make claims of cause 
and effect, were self-
selected into each group; 
patients were 
predominantly 
Caucasian  
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opioid use 
disorder improve 
outcomes for 
mother and child? 
Lander, L. R., 
Gurka, K. K., 
Marshalek, P. J., 
Riffon, M., & 
Sullivan, C. R. 
(2015). A 
Comparison of 
Pregnancy-Only 
versus Mixed-
Gender Group 
Therapy among 
Pregnant Women 
with Opioid Use 
Disorder. Social 
Work Research, 
39(4), 235-244. 
doi:10.1093/swr/s
vv029 
Purpose 
statement:  
“This study aimed 
to determine 
whether treating 
pregnant women 
in pregnancy-only 
therapy groups 
improved 
outcomes 
compared with 
treatment in 
mixed-gender 
therapy groups” 
(p. 1) 
 
Research 
question: 
Do pregnant 
women in 
pregnancy-only 
therapy groups 
show more 
improvement than 
pregnant women 
in mixed-gender 
therapy groups? 
Setting: 
Comprehensive 
Opioid Addiction 
Therapy (COAT) 
outpatient clinic in 
West Virginia 
Sampling Method: 
“inclusion criteria 
included 
pregnancy with 
opioid use 
disorders and 
seeking 
medication-
assisted treatment 
with 
buprenorphine. To 
meet eligibility, 
participants were 
required to obtain 
prenatal care and 
sign a release of 
information for 
study staff to 
abstract pregnancy 
and birth-related 
data from their 
medical record. 
Participants also 
were required to 
sign the COAT 
clinic treatment 
Design: 
Randomized 
control trial 
Level of 
evidence: 
Level II 
Findings:  
“The difference in these 
retention rates between the 
two groups was not 
significant” (p.5) 
Conclusion: 
“Our initial hypothesis was 
that a pregnancy-only group 
would be superior to TAU 
in terms of retention in 
treatment, lower rates of 
relapse, patient satisfaction, 
and quality-of-life 
measurements. Our findings 
suggest that the two groups 
were very similar on all 
measures. From this study, 
it appears that one of the 
most important factors in 
managing pregnant patients 
with opioid use disorders is 
to reduce barriers to 
treatment and treat opioid 
dependence itself.” (p.8) 
Practice and Research 
Implications: “Limitations of 
the study include the low 
number of participants who 
actually completed the study 
(only half of those 
consented), therefore limiting 
our ability to determine 
statistical significance among 
our primary dependent 
variables of retention and 
relapse rates. In addition, the 
explicit content of the 
OBGYN-affiliated providers’ 
group discussion was not 
structured, nor were 
satisfaction ratings 
administered specific to these 
group sessions. Perhaps if 
this portion of the 
intervention were more 
prescribed it would have 
added to the efficacy of the 
intervention, and the impact 
could have been more 
explicitly measured and 
replicated.”(p.8)  
Limitations: Small sample 
size of only 45. 
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agreement 
guidelines” (p.3) 
Sample size: 
45 pregnant 
women 
Lowe, J., Qeadan, 
F., Leeman, L., 
Shrestha, S., 
Stephen, J. M., & 
Bakhireva, L. N. 
(2017). The effect 
of prenatal 
substance use and 
maternal 
contingent 
responsiveness on 
infant affect. 
Early Human 
Development, 
115, 51–59. 
https://doi.org/10.
1016/j.earlhumde
v.2017.09.013 
.Purpose 
Statement: The 
specific aims of 
this prospective 
cohort study were 
to examine: 1) the 
differences in 
maternal behavior 
styles during the 
SFP between 
women who used 
alcohol, opioids, 
both substances in 
combination, or 
abstained from 
alcohol and illicit 
drugs during 
pregnancy; 2) the 
contributing 
effects of prenatal 
substance use and 
parenting style 
(operationalized 
as maternal 
contingent 
responding) on 
infant positive 
affect during 
maternal-infant 
play episodes of 
the SFP. We 
hypothesized that 
Setting:  two 
consecutive 
prospective cohort 
studies conducted 
at the University of 
New Mexico 
(UNM) with the 
same study 
population  
Sample methods:  
“A prospective 
cohort design was 
utilized with 
repeated 
assessment of 
substance use 
during pregnancy 
and the 
administration of 
the SFP, which 
measures infant 
response to a social 
stressor, at 
approximately 6 
months of age. 
Subjects included 
91 dyads classified 
into four groups: 1) 
Control (n = 34); 
2) Medication 
assisted therapy for 
opioid dependence 
 
Design: Data 
were derived 
from two 
consecutive 
prospective 
cohort studies 
conducted at 
the University 
of New Mexico 
(UNM) with the 
same study 
population. The 
UNM Human 
Research 
Review 
Committee 
approved both 
studies and 
patients gave 
written 
informed 
consent. The 
Biomarkers, 
Infant 
Neurodevelopm
ent, and Growth 
(BINGO) study 
was conducted 
at UNM in 
2011–2012 and 
served as a pilot 
Findings: “The results of 
this study support and 
expand our previous 
findings in a different 
population [47], that a 
supportive parenting style, 
which includes 
acknowledgement of infant 
affect (such as when they 
were happy or sad) and uses 
playful games to re-engage 
the infant (such as peek-a-
boo) explained more 
variability in infant 
emotional regulation than 
prenatal exposure to alcohol 
and/or opioids. With respect 
to exposure to substances of 
abuse, there were no 
significant effects of 
prenatal substance exposure 
on infant affect, although 
there was a trend (p = 
0.053) for a lower infant 
affect in the Alcohol group 
compared to Controls in the 
last reunion/play episode, 
when the child is more 
likely to accumulate “carry-
over effect” from prior SFP 
episodes. The lack of 
influence of prenatal 
Practice and Research 
Implications: “Future 
directions may include 
developing strategies for 
teaching parents who have 
infants prenatally exposed to 
alcohol and other substances 
how to respond in a sensitive 
manner that is responsive to 
their infant's emotion. 
Parents can be taught that 
certain behaviors, such as 
attention seeking, can be less 
pleasing or possibly 
annoying to their infant, 
while simple games, such as 
‘peek-a-boo,’ can be fun and 
engaging. This could 
potentially help improve 
infants' positivity, which is 
relevant as children 
prenatally exposed to alcohol 
have been found to have 
problems with ‘negative 
affectivity’ and irritability . 
Future work should also 
explore mediation analysis in 
the context of the SFP, 
focusing on the complexity 
of controlling for postnatal 
environment and maternal 
interaction as mediators. 
Limitations of Findings:  
“The SFP has been used 
extensively in the 
literature, but is only a 
proxy for a stressful 
situation; one can only 
infer that the measure of 
affect indicates the 
infant was upset and 
therefore stressed. Early 
in life there are many 
situations that cause an 
infant to become upset, 
and the ability to self-
calm or be soothed by a 
parent can be indicative 
of the infant's ability to 
regulate their emotions. 
We acknowledge that 
the limited effect of 
prenatal exposure on 
infant affect could be 
due to the following 
reasons: 1) small sample 
size in the Alcohol 
group, which potentially 
resulted in the results 
being of borderline 
statistical significance; 
2) light-to-moderate 
levels of alcohol 
consumption in this 
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substance using 
women will be 
less likely to 
engage in 
contingent 
responding 
behavior style, 
and that maternal 
contingent 
responding would 
be an equally 
important 
predictor of infant 
affect as prenatal 
exposure to 
substances of 
abuse.” (p. 2) 
Research 
Question: How 
does the maternal 
contingent 
responding of 
substance using 
women effect 
infant affect as 
prenatal exposure 
to substances of 
abuse? 
(MAT; n = 19); 3) 
Alcohol (n = 15); 
4) Alcohol + MAT 
(n = 23). Mean % 
of positive infant 
affect and mean % 
of maternal 
responsiveness 
(watching, 
attention seeking, 
and contingent 
responding) was 
compared among 
the five SFP 
episodes across the 
four study groups 
by MANOVA. 
Mixed effects 
modelling was 
used to estimate 
the contributing 
effect” (p. 1). 
Sample size: 91 
maternal-infant 
pair 
 
study to the 
larger, ongoing 
Ethanol, 
Neurodevelopm
ent, Infant and 
Child Health 
(ENRICH) 
cohort study, 
which began in 
2013. 
Participants 
were recruited 
from UNM-
affiliated 
prenatal care 
clinics. Both 
studies included 
three visits: 1) 
prenatal, during 
one of the first 
prenatal care 
appointments; 
2) early 
postpartum, 
during the 
hospital stay 
after labor and 
delivery; and 3) 
neurodevelopm
ental and SFP 
assessment of 
children at ~6 
months of age. 
The following 
eligibility 
criteria were 
applied to all 
substance exposures is 
further supported by the 
result indicating that the 
model containing maternal 
contingent responding 
accounted for 67% of the 
variance, in contrast to 16% 
for the model testing the 
group effect.” (p. 7). 
Conclusions: “In 
conclusion, we found that 
infants of mothers who used 
contingent responsiveness 
demonstrated more positive 
affect during play episodes 
of the SFP. Additionally, 
infants displayed less 
positivity when their 
mothers used attention 
seeking behaviors. Maternal 
behavior did not vary 
among the exposed and 
unexposed subjects; 
however, maternal behavior 
had a much greater 
influence on infant affect 
compared to prenatal 
exposures. Our findings are 
relevant to infants exposed 
to drugs and alcohol, as they 
are often described as 
dysregulated, easily 
overstimulated, and 
irritable. These results are 
important because they 
suggest that modifiable 
postnatal factors play a role 
Future studies should 
examine the effects of the 
timing of exposure and 
different patterns of 
substance use on infant stress 
reactivity. Finally, 
longitudinal studies should 
also explore if the 
improvement of infant-
mother interactions lead to 
decreased behavioral 
problems and/or improved 
social functioning across 
childhood in this vulnerable 
population.” (p. 8) 
sample, especially 
beyond the 
periconceptional period; 
3) prenatal substance 
exposure being a more 
distant measure as 
compared to maternal 
behavior which is 
measured in the same 
dyadic context during 
the SFP. Furthermore, 
assessing infant affect 
and maternal interaction 
style within the same 
paradigm limits the 
generalizability of the 
results; future studies 
would benefit from 
evaluating the effect of 
parental style earlier in 
life on more distant 
infant behavioral 
outcomes. Though there 
were demographic 
differences between the 
groups, these were 
controlled for in the 
multivariable analyses. 
Co-exposures with other 
substances, especially 
tobacco and marijuana, 
were prevalent among 
the three exposed 
groups; however, since 
Controls had no co-
exposure to these 
substances by definition, 
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participants: 1) 
at least 18 years 
old; 2) 
singleton 
pregnancy; 3) 
currently 
residing and 
planning to stay 
in the 
Albuquerque 
metropolitan 
area to 
complete all 
study visits; 4) 
ability to give 
informed 
consent in 
English; and 5) 
no fetal 
diagnosis of a 
major structural 
anomaly. 
Pregnant 
women in both 
cohort studies 
were recruited 
into one of four 
mutually 
exclusive study 
groups, as 
follows: 
participants 1) 
without 
perinatal 
substance 
exposures 
(Control); 2) 
in infant positivity, which 
may help mediate effects of 
prenatal substance 
exposures” (p. 8). 
 
 
 
we could not adjust for 
them in multivariable 
analyses. Finally while 
we controlled for the key 
socio-demographic 
(marital status, maternal 
education, family 
income), medical 
(depressive symptoms), 
and infant (age at 
assessment, sex) factors, 
we recognize that there 
are multiple other pre- 
and postnatal factors 
which can affect infant 
stress reactivity and 
maternal behavior.”(pg 
7, paragraph 6) 
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with opioid use 
disorder who 
prenatally 
received 
medication 
assisted therapy 
(MAT; either 
methadone or 
buprenorphine) 
and did not use 
alcohol in 
pregnancy; 3) 
with alcohol 
use during 
pregnancy 
(Alcohol); and 
4) with MAT 
and alcohol use 
during 
pregnancy 
(Alcohol + 
MAT). While 
the focus of 
both cohorts 
was to ascertain 
the effects of 
prenatal alcohol 
exposure on 
infant 
outcomes, 
MAT and 
Alcohol + 
MAT groups 
were included, 
in addition to 
unexposed 
controls, to 
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better match 
pre- and post-
natal 
environmental 
factors across 
groups. 
Participants 
classified into 
the control 
group needed to 
1) be a lifetime 
abstainer of 
illicit drugs and 
tobacco 
products 
(reported use of 
≤100 cigarettes 
in lifetime); and 
2) abstain from 
alcohol use 
since the last 
menstrual 
period (LMP) 
and be no more 
than a light 
alcohol user (≤2 
standard drinks/ 
week on 
average) before 
the LMP. 
Participants 
classified into 
the alcohol-
exposed groups 
(Alcohol, 
Alcohol + 
MAT) had to 1) 
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self-report at 
least moderate 
levels of 
drinking [37] in 
the 
periconceptiona
l period (≥3 
drinks per week 
or ≥2 binge 
drinking 
episodes 
[‘binge’ defined 
as ≥4 drinks per 
occasion] 
during the 
month 
surrounding the 
LMP) using the 
Timeline 
Follow-Back 
assessment 
method; and 2) 
continue 
drinking during 
pregnancy, as 
confirmed by 
self-report or 
positive ethanol 
biomarker. The 
self-reported 
cutoffs for risky 
alcohol use 
employed in 
this study and 
our conjunctive 
use of ethanol 
biomarkers in 
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pregnancy are 
rigorous and 
well-supported 
by the literature 
[37–41]. The 
final sample 
size for this 
analysis was 91 
maternal-infant 
pairs who had 
completed the 
three study 
visits as of 
January 2017.” 
(p. 2) 
Level of 
Evidence: 
Level 4 
 
Lubbe, M., Walbeek, C.V., 
& Vellios, N. 
(2017). The 
prevalence of 
fetal alcohol 
syndrome and its 
impact on a 
child’s classroom 
performance: A 
case study of rural 
south african 
school.  Internatio
nal Journal of 
Environmental 
Research and 
Public Health. 14, 
1-10. doi: 
Statement: The 
study aims to 
reveal the 
prevalence of 
FAS is a rural 
South African 
school to observe 
the effects of FAS 
on students’ 
abilities, 
interactions and 
education 
Setting: A farm 
school in rural 
South Africa near 
Clanwilliam in the 
South Western 
Cape 
Sampling  
Method: Students 
were chosen from 
the poorest district, 
or quantile in 
Clanwilliam. The 
students attending 
this school are 
more likely to be 
neglected 
physically and 
emotionally at 
Design:  Seven 
months were 
spent observing 
the language, 
mathematics, 
reading, and 
behavior 
abilities of the 
166 students. 
The data was 
observed by the 
researcher and 
collected by the 
teachers. The 
researchers 
used the 
Behavioral 
Observation of 
Findings: 21 students were 
diagnosed with FAS. In all 
four categories of learning 
children with FAS had 
lower performance than 
those without FAS. 
Conclusion: The prevalence 
of FAS is higher in farm 
regions than in towns and 
students with FAS perform 
worse in educational 
markers. The reason that 
there is not a higher 
difference in the 
performance of students 
with and without FAS could 
be because the majority of 
students come from homes 
Research Implications: 
Students who have FAS 
should be placed in learning 
environments that are noise 
controlled, with less stimuli. 
Limitations of findings 
Limitations: There is a 
small sample size. Only 
FAS not all FASD were 
diagnosed. There is a 
possibility of bias or 
error in the measurement 
of the educational 
outcomes. 
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10.3390/ijerph140
80896. 
home. 
Consumption of 
alcohol in large 
quantities is not 
uncommon in this 
community. 
Alcohol is made at 
home illegally and 
sold. Workers 
receive pay checks 
on Fridays and sell 
alcohol at the 
farms where they 
work 
 
Students in 
School (BOSS). 
TO collect data 
on behaviors, 
each student 
underwent two 
15-minute 
BOSS sessions 
over six 
months. A 
medical doctor 
in the area 
provided data 
on the diagnosis 
of FAS on each 
student. 
Information 
was 
documented on 
the FAS 
assessment 
form 
Level of 
Evidence: V 
that are dysfunctional to 
some significant degree 
Mark, K., Desai, 
A., & Terplan, M. 
(2015). Marijuana 
use and 
pregnancy: 
Prevalence, 
associated 
characteristics, 
and birth 
outcomes. 
Women’s Mental 
Health 
Purpose 
Statement: “This 
study examined 
the prevalence, 
behaviors, and 
birth outcomes 
associated with 
marijuana use in 
pregnancy” (pg 1) 
 
Research 
question: What 
does the 
Sample size: 398 
patients  
Setting: single 
urban university 
affiliated clinic 
from July 1 2009- 
June 30 2010 
Sample methods: 
intake data 
retrieved from the 
prenatal chart 
which included a 
Design: a chart 
review of all 
patients 
presenting for 
prenatal care; 
retrospective 
cohort 
Level of 
evidence: Level 
III 
Findings: intake 116 
(29.3%) screened positive 
for marijuana either by self-
report or urine toxicology. 
116, 27 were positive by 
urine only, 35 by self-report 
only, 54 by both urine by 
both urine and self-report 
Conclusion: prevalence of 
marijuana that reported at 
29.3% was higher than that 
reported in the national 
survey on drug use and 
Research implications: 
Despite the high prevalence 
of marijuana use prenatal 
care, most women stopped 
using marijuana during 
pregnancy. Only three 
women had a positive 
toxicology screen at the time 
of delivery 
Limitations to findings: 
retrospective cohort that 
relies partially on 
provider documentation 
of screening. May have 
had selection bias, not 
consistently screened 
with urine toxicology. 
Frequency of marijuana 
use was not elicited nor 
was detailed information 
about a quit date 
obtained.  
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prevalence of 
marijuana use 
during 
pregnancy? 
complete social 
work eval.  
health. Despite high 
prevalence, most of the 
women stopped using 
marijuana during pregnancy 
May, P.A., 
Chambers, C.D., 
Kalberg, W.O., 
Zellner, J., 
Feldman, H., 
Buckley, D., & 
Hoyme, H.E. 
(2018). 
Prevalence of 
fetal alcohol 
spectrum 
disorders in 4 US 
communities. 
American 
Medical 
Association. 
.doi:10.1001/jama
.2017.21896 
Purpose 
Statement: “To 
estimate the 
prevalence of 
fetal alcohol 
spectrum 
disorders, 
including fetal 
alcohol syndrome, 
partial fetal 
alcohol syndrome, 
and alcohol-
related 
neurodevelopmen
tal disorder in 4 
regions of the 
United States 
Research 
question: How 
prevalent are fetal 
alcohol spectrum 
disorders in the 
United States? 
Setting: Four 
Communities in 
the Rocky 
Mountain, 
Midwestern, South 
Eastern, and 
Pacific 
Southwestern 
regions of the 
United States 
 
Sampling Method: 
First-grade 
children and their 
parents or 
guardians. A cross 
sectional design 
was used to assess 
children for fetal 
alcohol spectrum 
disorders between 
2010-2016. 
Children were 
systematically 
assessed in the four 
domains that 
contribute to the 
fetal alcohol 
spectrum disorder: 
dysmorphic 
features, physical 
growth, 
neurobehavioral 
Design: Active-
case 
ascertainment 
with a cross-
sectional design 
was used at 4 
community 
sites, a 
convenience 
sample that was 
selected based 
on the 
investigators’ 
ability to 
engage the 
individual 
communities 
and on the 
feasibility of 
conducting the 
study in that 
community 
 
Level of 
Evidence: 
Level V or VI  
Findings: Prevalence of 
fetal alcohol spectrum 
disorders in the 4 
communities was the main 
outcome. Conservative 
estimates for the prevalence 
of the disorder and 95% CIs 
were calculated using the 
eligible first-grade 
population as the 
denominator. Weighted 
prevalence and 95% CIs 
were also estimated, 
accounting for the sampling 
schemes and using data 
restricted to children who 
received a full evaluation. 
222 cases of fetal alcohol 
spectrum disorders were 
identified. The conservative 
prevalence estimates for 
fetal alcohol spectrum 
disorders ranged from 11.3 
(95% CI, 7.8-15.8) to 50.0 
(95% CI, 39.9-61.7) per 
1000 children. The 
weighted prevalence 
estimates for fetal alcohol 
spectrum disorders ranged 
from 31.1 (95% CI, 16.1-
54.0) to 98.5 (95% CI, 57.5-
139.5) per 1000 children 
 
Practice and Research 
Implications: Findings may 
represent more accurate US 
prevalence estimates than 
previous studies but may not 
be generalizable to all 
communities. 
Limitation of Findings: 
due to local policy 
variations in the modes 
of access allowed for 
recruitment of children, 
as well as variability in 
willingness to consent, 
no individual sample 
evaluated the entire 
eligible population. 
Consent rates for 
screening ranged from 
36.9%-92.5% in 
individual samples and 
overall consent rates for 
screening averaged only 
59.9% of eligible 
children. If non 
consented children 
differed from consented, 
this could have biased 
prevalence estimates in 
either direction. Second: 
numbers of cases of each 
category of fetal alcohol 
spectrum disorder in 
each sample are small, 
leading to wide CIs. 
Third: neurobehavioral 
testing at this age may 
have missed some 
children with deficits 
that would no become 
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development, and 
prenatal alcohol 
exposure 
 
Sampling Size: 
6639 Children 
from a population 
of 13,146 first 
graders (boys, 
51.9%; mean age 
6.7 years old and 
white maternal 
race, 79.3% 
Conclusion: Estimated 
prevalence of fetal alcohol 
spectrum disorders among 
first graders in 4 US 
communities ranged from 
1.1%-5.0% using a 
conservative approach. 
These findings may 
represent more accurate US 
prevalence estimates than 
previous studies but may 
not be generalizable to all 
communities 
apparent until later ages, 
which could have led to 
underestimation of rates. 
Fourth: this cross-
sectional study was 
neither a longitudinal 
nor a clinical sample. 
Fifth criteria defining 
neurobehavioral 
impairment in this study 
were selected to balance 
sensitivity for deficits 
that have functional 
consequences with 
specificity for the 
characteristic 
neurobehavioral 
domains known to be 
affected by prenatal 
alcohol exposure. Also, 
these four communities 
in the study might not be 
the greatest 
representation for the 
United States overall 
Metz, V. E., 
Brown, Q. L., 
Martins, S. S., & 
Palamar, J. J. 
(2018). 
Characteristics of 
drug use among 
pregnant women 
in the United 
States: Opioid and 
non-opioid illegal 
drug use. Drug & 
Purpose 
Statement: “...the 
aims of this study 
were to: 1) 
examine 
associations 
between 
sociodemographic 
characteristics, 
mental health 
characteristics, 
and substance use 
Setting: “The study 
included data from 
women aged 18–44 
years from the 
National Survey on 
Drug Use and 
Health (NSDUH), 
years 2005–2014. 
The NSDUH is an 
annual, cross-
sectional, 
nationally 
Design: “Data 
on pregnant 
women aged 
18–44 reporting 
past-year, 
nonmedical 
opioid use or 
use of non-
opioid illegal 
drugs (other 
than marijuana) 
were analyzed 
Findings: “Most women 
were non-Hispanic White 
(67.6%), had a high school 
diploma or less education 
(61.0%), a household 
income < $20,000/year 
(72.2%), and health 
insurance coverage (84.3%). 
No significant differences 
between the three groups 
were found regarding 
sociodemographic 
Practice and Research 
Implications: “Despite 
comparable 
sociodemographic 
characteristics among 
pregnant drug-using women 
in the US, opioid and non-
opioid-using groups differed 
regarding mental health 
status and substance use 
severity. This calls attention 
to the need for access to 
Limitations of Findings: 
“We could not determine 
whether self-reported 
past-year drug use 
occurred only before 
pregnancy or whether 
these women were 
aware, they were 
pregnant when 
(continuing) using drugs. 
Furthermore, due to the 
study’s cross-sectional 
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Alcohol 
Dependence, 183, 
261–266. 
https://doi.org/10.
1016/j.drugalcdep
.2017.11.010 
 
profiles in order 
to identify 
correlates of 
nonmedical 
opioid use (i.e., 
nonmedical only-
opioid versus 
opioid polydrug 
use) and non-
opioid illegal drug 
use during 
pregnancy, and 2) 
estimate the 
prevalence of 
cigarettes, 
alcohol, and 
marijuana use by 
pregnancy 
trimester and 
examine whether 
use is correlated 
with nonmedical 
opioid and/or 
other illegal drug 
use.” (pg 2, 
paragraph 2) 
Research 
Question: How 
does 
sociodemographic
, mental health, 
and drug use 
characteristics 
correlate with 
prevalence of 
nonmedical 
opioid and/or 
representative 
survey that 
assesses substance 
use and other 
behaviors among a 
probability sample 
of non-
institutionalized 
individuals living 
in households 
within the 50 US 
states and the 
District of 
Columbia ages 12 
years and older 
(Substance Abuse 
and Mental Health 
Services 
Administration" 
(pg 2, paragraph 3)  
Sample methods: 
“Surveys were 
administered via 
computer-assisted 
interviewing, 
conducted by an 
interviewer, and 
audio computer-
assisted self-
interviewing. 
Interviewers were 
trained to not view 
the screens during 
survey 
administration to 
maintain the 
privacy and 
from the 
National 
Survey on Drug 
Use and Health 
(2005–2014). 
Women (N = 
818) were 
categorized into 
3 groups: 1) use 
of opioids only 
(n = 281), 2) 
opioid polydrug 
users (n = 241), 
and 3) other 
(non-opioid) 
illegal drug 
users (n = 296). 
Characteristics 
between the 3 
groups of 
women were 
compared using 
bivariable 
analysis.” (p.1) 
Level of 
Evidence: 
Level 6 
 
characteristics. Past-30-day 
marijuana use was less 
prevalent among opioid-
only users (10.9%) 
compared to opioid-
polydrug users (43.6%) and 
other pregnant illegal drug 
users (27.6%) (P < 0.001) 
and past-year drug/alcohol 
treatment was less prevalent 
among opioid-only users 
(6.3%) compared to opioid-
polydrug users (20.3%) and 
other illegal drug users 
(8.3%) (P = 0.002). Opioid-
only users also reported 
lower prevalence of past-
year depression (P < 0.001) 
and anxiety (P = 0.039)” 
(pg 1, paragraph 3) 
Conclusions: “Pregnant 
drug-using women were 
often of low socioeconomic 
status, with mental health 
and substance use patterns 
suggesting the need for 
targeted mental 
health/substance use 
screening and interventions 
before and during 
pregnancy, particularly for 
opioid-polydrug use” (p. 1) 
mental health and drug use 
screening for women of 
childbearing age with low 
socioeconomic status, as well 
as for more targeted 
prevention efforts aimed at 
educating women of the risk 
of prenatal substance use, 
and the need for non-
stigmatizing treatment 
approaches for women who 
misuse opioids and other 
illegal drugs during all stages 
of pregnancy” (p.5). 
 
design, causality cannot 
be inferred. In addition, 
there might be trends 
that could not be 
accounted for, such as 
that the proportion of 
non-opioid illegal drug 
using women decreased 
over time. Also, 
sensitivity analyses for 
past-month use could not 
be conducted due to too 
few women in many 
cells. This study only 
included non-
institutionalized women, 
so individuals not 
included in the sample 
(e.g., homeless) may be 
underrepresented and 
results may be less 
generalizable to such 
populations” (p. 5).  
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another illegal 
drug use?  
confidentiality, and 
to increase the 
likelihood of 
honest reporting 
(Butler et al., 
2011). All 
variables were self-
reported. Sampling 
weights were 
provided by 
NSDUH to account 
for unit- and 
individual-level 
non-response and 
adjusted to ensure 
estimates were 
consistent with 
estimates provided 
by the US Census 
Bureau. 
Aggregated data 
from all cohorts of 
pregnant women 
aged 18–44 who 
reported past-year, 
nonmedical opioid 
use and/or other 
non-opioid illegal 
drug use (other 
than marijuana) 
were examined (N 
= 818). Analyses 
were restricted to 
this subset of 
women, which is 
consistent with 
previous literature 
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examining prenatal 
substance use 
among adults 
(Brown et al., 
2017; Ko et al., 
2015). The 
weighted interview 
response rates 
ranged from 71.2–
76.0% annually” 
(p.2). 
Sample size: 818 
pregnant women 
aged 18–44 years 
who reported past-
year nonmedical 
opioid use and/or 
another non-opioid 
illegal drug use 
Nørgaard, M., 
Nielsson, M. S., 
& Heide-
Jørgensen, U. 
(2015). Birth and 
Neonatal 
Outcomes 
following Opioid 
Use in Pregnancy: 
A Danish 
Population-Based 
Study. Substance 
Abuse: Research 
and Treatment, 
9s2. 
 
Purpose 
Statement:  
To examine 
“adverse birth 
outcomes in 
women exposed 
to methadone or 
buprenorphine 
during pregnancy 
and the risk of 
neonatal 
abstinence 
syndrome (NAS) 
among neonates 
exposed to 
buprenorphine, 
methadone, 
Setting: 
Denmark 1997–
2011 
Sampling method: 
“We included all 
pregnant women 
who during the 
period 1997–2011 
gave a live birth or 
a stillbirth after the 
20th week of 
gestation. The 
women were 
identified through 
the Danish Medical 
Birth Registry,17 
which contains 
computerized 
Design: 
“The women 
were identified 
through the 
Danish Medical 
Birth 
Registry,17 
which contains 
computerized 
records of all 
births in 
Denmark since 
January 1, 
1973. Data 
were recorded 
by the 
midwives or the 
physicians 
Findings: 
“we identified 557 
pregnancies exposed to 
buprenorphine, methadone, 
and/or heroin (167 to 
buprenorphine, 197 to 
methadone, 28 to self-
reported heroin, and 165 to 
combinations)” (p. 1) 
Conclusion:  
“maternal use of 
buprenorphine and 
methadone during 
pregnancy was associated 
with increased prevalence 
of adverse birth outcomes, 
and this increase could only 
be explained to a smaller 
Practice and Research 
Implications: 
“We 
had no method of identifying 
women with an illicit use of 
opioids who were not 
undergoing treatment. It is 
thus likely that we 
have misclassified some of 
the exposed women as 
unexposed, 
which would bias our relative 
estimates toward the null” (p. 
9). 
Limitations: 
“A major weakness of 
our study is that the use 
of prescription 
data to identify the users 
of buprenorphine did not 
allow us to 
distinguish between 
prescriptions for 
analgesic purposes only 
and prescriptions to 
opioid-dependent 
women” (p. 10) 
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and/or heroin in 
utero” (p. 1). 
records of all births 
in Denmark since 
January 1, 1973” 
(p.1) 
Sample size: 
“950,172 
pregnancies in a 
total of 571,823 
women” (p.1). 
attending the 
deliveries. The 
registry 
includes 
information on 
maternal age, 
parity, 
multiplicity of 
gestation, birth 
weight, 
gestational age, 
self-reported 
maternal 
smoking status, 
and delivery. 
We obtained 
information on 
exposure by 
combining data 
from the Danish 
Register of 
Medicinal 
Product 
Statistics, and 
from the 
Registry of 
Drug Abusers 
Undergoing 
Treatment.19 
We linked all 
data using the 
10-digit civil 
registration 
number (the 
CPR number) 
which is a 
unique 
extent by increased 
prevalence of smoking. The 
risk of NAS was eight-fold 
higher in methadone-
exposed neonates than that 
in buprenorphine-exposed 
neonates, but this difference 
may at least partly be 
explained by differences in 
underlying indications 
(analgesic versus opioid 
maintenance treatment) 
between the two groups” 
(p.1). 
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identifier 
assigned, since 
1968, to all 
Danish 
residents by the 
Central Office 
of Civil 
Registration 
and used in all 
Danish 
healthcare 
registries" (p.2)  
Osterman, R.L., 
Carle, A.C., 
Ammerman, R.T., 
& Gates, D. 
(2014). Single-
session 
motivational 
intervention to 
decrease alcohol 
use during 
pregnancy. 
Journal of 
Substance Abuse 
Treatment 
Purpose 
Statement: the 
effectiveness of a 
single session of 
motivational 
interviewing (MI) 
to decrease 
alcohol use during 
pregnancy  
 
Research 
question:  Is a 
single session of 
motivational 
interviewing 
intervention 
effectively 
decrease alcohol 
use during 
pregnancy? 
Setting: recruited 
pregnant women at 
three prenatal 
clinics located in a 
midwestern 
university medical 
center. Women 
attending an 
obstetrical clinic 
treating low-
moderate risk 
pregnancies, a 
high-risk perinatal 
center, or a nurse 
practitioner/midwif
ery practice 
consented to 
participate in the 
study (N=184). To 
determine study 
eligibility, 
consenting women 
completed baseline 
demographic 
information and 
Design:  
randomized 
clinical trial.  
 
Level of 
Evidence: 
Level II 
Findings: A single-session 
MI approach was not 
effective in decreasing 
alcohol use during 
pregnancy. 
 
Conclusion: “Theory-based 
influencers of behavior 
change should be 
considered to provide 
interventions with the 
greatest potential to 
decrease prenatal alcohol 
use in pregnant women less 
motivated and less ready for 
change” (p. 15). 
Practice and Research 
Implications: “Future studies 
can increase the number of 
sessions of the intervention 
to increase potency of the 
intervention” (p. 15). 
Limitation of Findings: 
all women in the current 
study were attending 
prenatal care visits with 
no prescriptions to the 
standard care or 
education provided 
regarding the risks of 
prenatal alcohol use. 
Another is the inability 
to interpret the 
curvilinear relationships 
in drinking behaviors 
due to only three time 
points of data collected 
was a study limitation. 
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instruments 
measuring alcohol 
use for the 
previous 30 days 
and previous year. 
Pregnant women 
who were 36 
weeks or less 
gestation, between 
the ages of 18 and 
44 years inclusive, 
able to understand, 
speak, and read 
English, who 
reported any 
alcohol use in the 
previous year, and 
being available for 
telephone follow-
ups at 30 days 
postbaseline and 
30 days postpartum 
were eligible 
 
Sampling Method: 
Eligible pregnant 
women who drank 
any amount of 
alcohol in the 
previous year 
(n=122) were 
randomized to an 
intervention or 
comparison group 
 
Sampling Size:  
INTERVENTIONS FOR DRUG USE IN PREGNANCY                                                       55 
 
122 pregnant 
women 
Patrick, S. W., 
Dudley, J., 
Martin, P. R., 
Harrell, F. E., 
Warren, M. D., 
Hartmann, K. E., 
… Cooper, W. O. 
(2015). 
Prescription 
Opioid Epidemic 
and Infant 
Outcomes. 
Pediatrics, 
135(5), 842–850. 
https://doi.org/10.
1542/peds.2014-
3299 
Purpose 
Statement: “to 
identify neonatal 
complications 
associated with 
antenatal opioid 
pain reliever 
exposure and to 
establish 
predictors of 
neonatal 
abstinence 
syndrome 
(NAS).” (p. 1) 
 
Research 
question: 
Is the use of 
opioid painkillers 
during pregnancy 
associated with 
negative neonatal 
outcomes like 
neonatal 
abstinence 
syndrome?  
 
. Setting:  
“prescription and 
administrative data 
linked to vital 
statistics for 
mothers and 
infants enrolled in 
the Tennessee 
Medicaid program 
between 2009 and 
2011” (p. 1). 
Sampling method: 
“Maternal and 
infant dyads were 
included in the 
study if: (1) the 
mother was 15 to 
44 years old at the 
time of delivery; 
(2) the mother had 
been enrolled in 
TennCare at least 
30 days before 
delivery; and (3) 
the infants were 
enrolled in 
TennCare within 
30 days after 
delivery. Last 
menstrual period 
and date of 
delivery were 
obtained from vital 
records.17 
Pregnancies were 
Design:  
“retrospective, 
longitudinal 
cohort study 
Level of 
Evidence: 
Level IIII 
Findings: “Of pregnant 
women, 28% filled one or 
more opioid prescription. 
Women prescribed opioid 
pain relievers were more 
likely than those not 
prescribed opioids to have 
depression (5.3% vs 2.7%), 
anxiety disorder (4.3% vs 
1.6%) and to smoke tobacco 
(41.8% vs 25.8%). Infants 
with NAS and opioid-
exposed infants were more 
likely than unexposed 
infants to be born at a low 
birth weight (21.2% vs 
11.8% vs 9.9%). In a 
multivariable model, higher 
cumulative opioid exposure 
for short-acting preparations 
(P , .001), opioid type (P , 
.001), number of daily 
cigarettes smoked (P , .001), 
and selective serotonin 
reuptake inhibitor use (odds 
ratio: 2.08 [95% confidence 
interval: 1.67–2.60]) were 
associated with greater risk 
of developing NAS.” (p. 1) 
 
 
Conclusion:” Prescription 
opioid use in pregnancy is 
common and strongly 
associated with neonatal 
Practice and Research 
Implications: “Prescription 
opioid use in pregnancy is 
common and strongly 
associated with neonatal 
complications. Antenatal 
cumulative prescription 
opioid exposure, opioid type, 
tobacco use, and selective 
serotonin reuptake inhibitor 
use increase the risk of 
neonatal abstinence 
syndrome” (p. 6). 
Limitations: Due to the 
use of hospital 
administrative and vital 
statistics data, errors of 
omission, and 
commission are possible, 
leading to 
misclassification bias; 
however, the medical 
record review suggested 
that potential 
misclassification of 
outcomes was likely to 
be small. There was no 
direct observation of 
women in our cohort 
taking the prescribed 
OPR. It is possible that 
OPR medications were 
not taken as prescribed, 
resulting in a bias 
toward the null 
hypothesis. Inability to 
capture other exposures 
(eg, illicit drugs) that 
may have influenced the 
primary outcome (NAS). 
Opioids obtained by 
other legal sources not 
paid for by TennCare 
(ie, cash payments) were 
not captured in the 
sample, which could 
bias the results toward 
the null hypothesis. 
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included if the 
birth occurred 
between January 1, 
2009, and 
December 31, 
2011. Of a total 
134450 births, 
11202” (p. 2). 
 
 
Sample size:   
112029 pregnant 
mothers 
complications. Antenatal 
cumulative prescription 
opioid exposure, opioid 
type, tobacco use, and 
selective serotonin reuptake 
inhibitor use increases the 
risk of NAS” (p. 1). 
 
 
. 
 
Conversion to morphine 
milligram 
equivalents may not 
create perfect 
comparisons of various 
OPRs. It is possible that 
opioid prescribing is a 
surrogate for other 
unmeasured risk factors 
for NAS; residual 
confounding cannot be 
completely ruled out.  
Rendall-Mkosi, 
K., Morojele, N., 
London, L., 
Moodley, S., 
Singh, C., & 
Girdler-Brown, B. 
(2013). A 
randomized 
controlled trial of 
motivational 
interviewing to 
prevent risk for an 
alcohol-exposed 
pregnancy in the 
Western Cape, 
South Africa. 
Addiction, 
108(4), 725-732. 
doi: 
10.1111/add.1208 
Purpose 
Statement: 
“To test the 
effectiveness of 
motivational 
interviewing (MI) 
to reduce the risk 
of an alcohol 
exposed 
pregnancy (AEP) 
in a high-risk 
population.” (p.1) 
Setting: “Rural 
population in the 
Western Cape, 
South Africa.” 
(p.1) 
Sampling methods: 
“Participants were 
recruited from six 
primary care 
clinics and from 
farms within the 
study area between 
June and 
November 2007. 
Eligibility criteria 
included: (i) age 
18–44 years; (ii) 
not pregnant; (iii) 
engaged in risky 
drinking (defined 
under Measures); 
(iv) ineffective or 
no contraceptive 
use (defined under 
Design: 
“Randomized 
control trial.” 
(p.1) 
Level of 
evidence:  
Level II 
Findings: “There was a 
significant difference in the 
decline in the proportion of 
women at risk for an AEP in 
the MI group at 3 months 
(50 versus 24.59%; P = 
0.004), maintained at 12 
months (50.82 versus 
28.12%; P = 0.009)” (p.1) 
 
Practice and Research 
Implications: “There were 
potential biases in this study. 
There are limitations with 
relying on self-reported data. 
In addition, the failure to use 
a timeline follow-back 
method to assess the 
women’s alcohol 
consumption may have 
reduced the reliability of self-
reports. Interview fatigue 
may have influenced them to 
answer what they thought the 
fieldworker would prefer to 
hear” (p. 7) 
 
 
Limitations: There was a 
small sample size, 
limited to a rural setting 
in Africa. 
 
 
 
INTERVENTIONS FOR DRUG USE IN PREGNANCY                                                       57 
 
Measures); (v) had 
not undergone 
sterilization or 
hysterectomy;(vi) 
had vaginal sex in 
the past 3 months; 
and resided within 
a 25-km radius of 
the main town.” 
(p.2) 
Random sampling. 
Sample size: 
“A total of 165 
women aged 18–44 
years at risk of 
AEP” (p.1) 
 
 
 
Savory, J., 
Couves, J., & 
Burns, E. (2014). 
Alcohol 
consumption 
during pregnancy: 
Cross-sectional 
survey. Midwifery 
 
Purpose 
Statement: “ to 
assess the 
prevalence and 
pattern of alcohol 
consumption pre-
conception and/or 
during the first 
trimester using 
the Alcohol Use 
Disorders 
Identification Test 
(AUDIT), 
Alcohol Use 
Disorders 
Identification Test 
– Consumption 
(AUDIT-C) and 
Setting: two 
antenatal clinics in 
the south west of 
England 
Sampling methods: 
Sample size: 500 
pregnant women 
attending their first 
antenatal 
appointment at 
approximately 10-
11 weeks gestation 
 
 
Design: Cross 
sectional survey  
. Level of 
Evidence: 
Level III 
Findings: quarter of women 
reported drinking alcohol 
despite being aware they are 
pregnant. Between two to 
three in every 100 women 
reported drinking six or 
more units on a single 
occasion at least monthly or 
weekly in the past three 
months, 
 Conclusion: these women 
were willing to complete 
brief alcohol screening 
questionnaires. Minority of 
the women reported 
drinking preconception and 
or during the first trimester 
with a small percentage 
 Practice & Research 
Implications: 
Use of these questionnaires 
would help midwives gather 
info about alcohol are used to 
help identify women 
drinking at levels in excess 
of recommended limits so 
that appropriate advice and 
support can be offered.  
Limitations of Findings: 
Alcohol intake was self-
reported by women and 
therefore they may be 
underreporting due to 
social stigma. They 
found difficulties with 
people’s perceptions of 
what constitutes a drink. 
Estimating quantity and 
frequency of alcohol 
consumed is difficult 
due to lack of 
understanding about 
alcohol units and is 
dependent on glass size 
and drink strength. 
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T-ACE 
(Tolerance, 
Annoyance, Cut 
Down and Eye-
Opener) alcohol 
screening 
questionnaires, 
and determine the 
socio-
demographic 
predictors of 
drinking in this 
time period” (pg 
1) 
Research 
Questions: What 
is the prevalence 
of alcohol during 
pregnancy? 
drinking at levels 
potentially harmful to the 
fetus. 
Warshak, C.R., 
Regan, J., Moore, 
B., Magner, K., 
Kritzer, S., & Van 
Hook, J. (2015). 
Association 
between 
marijuana use and 
adverse 
obstetrical 
neonatal 
outcomes. 
Journal of 
Perinatology 
 
Purpose 
Statement: “To 
evaluate 
associations 
between 
marijuana 
exposure and 
adverse outcomes 
excluding women 
with 
polysubstance 
abuse and 
stratifying for 
concurrent 
maternal tobacco 
use” (p. 1) 
 
Setting: The 
University of 
Cincinnati Medical 
Center between 
January 2008 and 
January 2011 
 
Sampling methods: 
Marijuana users 
were designated as 
such if they 
reported use during 
the course of their 
prenatal care or at 
the time of 
delivery or if at 
any point during 
the pregnancy they 
Design: 
retrospective 
cohort study 
 
 Level of 
Evidence: 
Level IV 
Finding: nonusers: n=6107 
(94.4%) users: n=361 
(5.6%). marijuana users 
tended to be slightly 
younger than nonusers, 24 
years versus 25.3 years. 
Marijuana users had 
clinically similar gestational 
ages at presentation for 
prenatal care. Did not find 
increased risks of several 
adverse obstetric outcomes 
in marijuana users versus 
non users including preterm 
delivery, pre-eclampsia, or 
unplanned cesarean 
delivery. Marijuana users 
had a lower rate of 
Practice & Research 
Implications: 
They had a large number of 
women included in their 
analysis and their ability to 
control the confounding 
medical and social factors 
(race, obesity and lack of 
adequate prenatal care) Rates 
of marijuana use are 
comparable to those 
generally reported and 
therefore they likely had 
reasonable ascertainment of 
use from the medical record.  
 
Limitations of Findings: 
The authors declare no 
conflict of interest. Their 
study was not designed 
to determine dose-
related effects and 
patients were 
characterized simply as 
users or nonusers 
although it is 
physiologically plausible 
that there may be 
differences in outcomes 
based upon increased 
use. There center is a 
high risk academic 
center with a large 
referral base and as such 
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Research 
Question: Is there 
an association 
between 
marijuana use and 
adverse 
obstetrical and 
neonatal 
outcome? 
had a positive 
toxicology screen 
for 
tetrahydrocannabin
ol universal drug 
screening was not 
used during the 
study period but 
was performed in 
pregnancies 
deemed to be high 
risk for substance 
abuse, secondary 
to known history 
of substance abuse, 
poor prenatal care 
or social/medical 
risk factors for 
drug abuse.   
   
 
Sample size: 6468 
pregnant women 
(6107 nonusers, 
361 users of 
marijuana) 
gestational diabetes and a 
lower rate of induction.  
 
Conclusion: Study did not 
find significant increases in 
these outcomes in women 
who also smoked tobacco.  
our rates of exposures 
and outcomes may vary 
from other regions. They 
only reported on 
outcomes to neonatal 
discharge. There is 
consistent data that 
marijuana exposure 
during pregnancy and 
breastfeeding contributes 
of long term cognitive 
gross motor and 
neurodevelopmental 
impairments in the 
offspring of these 
women 
 
 
 
